Compound specific isotope analysis to track sources and transformation processes of micropollutants  – Investigations in engineered and natural systems with a special focus on diclofenac and chiral herbicides by Maier, Michael
  
COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES 
AND TRANSFORMATION PROCESSES OF MICROPOLLUTANTS  
– 
INVESTIGATIONS IN ENGINEERED AND NATURAL SYSTEMS WITH 
A SPECIAL FOCUS ON DICLOFENAC AND CHIRAL HERBICIDES 
 
 
 
 
Dissertation 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Eberhard Karls Universität Tübingen 
zur Erlangung des Grades eines  
Doktors der Naturwissenschaften  
(Dr. rer. nat.) 
 
 
 
vorgelegt von 
Michael Maier 
aus Nürnberg 
 
 
Tübingen 
2014 
  
  
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
  
 
 
 
 
 
 
 
 
 
 
 
 
Gedruckt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der 
Eberhard Karls Universität Tübingen. 
 
 
Tag der mündlichen Qualifikation:  20.05.2015 
Dekan: Prof. Dr. Wolfgang Rosenstiel 
1. Berichterstatter: PD Dr. Martin Elsner 
2. Berichterstatter: Prof. Dr. Christian Zwiener 
3. Berichterstatter Prof Dr. Thomas Ternes 
  
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
  
TABLE OF CONTENTS 
1 General Introduction .................................................................................................................... 1 
1.1 Global challenges related to pesticides & pharmaceuticals ................................................. 2 
1.1.1 Occurrence of Micropollutants in the Environment ..................................................... 2 
1.1.2 Effects & Fate of Micropollutants in the Environment ................................................. 2 
1.1.3 Established Techniques to Investigate the Fate of Micropollutants ............................. 3 
1.1.4 Product Counterfeiting of Pharmaceuticals .................................................................. 4 
1.2 Principles of Enantioselective & Compound Specific Isotope Analysis (ESIA & CSIA) .......... 4 
1.2.1 Source Tracking of Micropollutants by CSIA ................................................................. 5 
1.2.2 Isotope Fractionation during Transformation Reactions .............................................. 6 
1.2.3 Principles of Enantioselective Isotope Analysis (ESIA) .................................................. 9 
1.3 Content of the present thesis ............................................................................................. 11 
1.3.1 Analytical Challenges & Objectives of CSIA and ESIA of Micropollutants ................... 11 
1.3.2 Challenge of large number of C-atoms in micropollutants ......................................... 13 
1.3.3 Challenge of process understanding ........................................................................... 13 
1.4 References .......................................................................................................................... 14 
2 C & N Isotope Analysis of Diclofenac to Distinguish Oxidative and Reductive Transformation 
and to Track Commercial Products ............................................................................................. 18 
2.1 Abstract ............................................................................................................................... 19 
2.2 Introduction ........................................................................................................................ 20 
2.3 Materials and Methods ....................................................................................................... 21 
2.3.1 Chemicals .................................................................................................................... 21 
2.3.2 Purification of Commercial Pharmaceutical Products and Treatment for Isotope 
Analysis ........................................................................................................................ 21 
2.3.3 Aerobic Biodegradation Experiment ........................................................................... 22 
2.3.4 Dechlorination Experiment ......................................................................................... 23 
2.3.5 Online Derivatization GC-IRMS Analysis ..................................................................... 23 
2.3.6 Offline Derivatization - Splitless Injection ................................................................... 24 
2.3.7 Offline Derivatization-On-Column Injection ............................................................... 24 
2.3.8 Extraction and Purification from River Water Samples .............................................. 25 
2.3.9 Post-Measurement Correction of Carbon Isotope Ratios ........................................... 25 
  
2.3.10 Evaluation of Isotope Fractionation ........................................................................... 26 
2.3.11 Evaluation of Degradation Kinetics ............................................................................ 27 
2.4 Results & Discussion ........................................................................................................... 27 
2.4.1 Method Validation & Quantification Limit .................................................................. 27 
2.4.2 Source Variability and Potential for Source Tracking.................................................. 29 
2.4.3 Isotope Fractionation During Degradation by Aerobic River Sediment ...................... 31 
2.4.4 Reductive dechlorination ............................................................................................ 33 
2.4.5 Environmental Significance ......................................................................................... 34 
2.4.6 Acknowledgements ..................................................................................................... 35 
2.5 References .......................................................................................................................... 36 
3 Isotope Fractionation of Diclofenac in Environmental & Engineered Systems: Evidence of 
Different Oxidation Mechanisms ................................................................................................ 40 
3.1 Abstract ............................................................................................................................... 41 
3.2 Introduction ........................................................................................................................ 42 
3.3 MATERIALS AND METHODS ................................................................................................ 44 
3.3.1 Chemicals .................................................................................................................... 44 
3.3.2 Phototransformation .................................................................................................. 44 
3.3.3 Ozonation .................................................................................................................... 44 
3.3.4 Oxidation by MnO2 ...................................................................................................... 45 
3.3.5 Single electron transfer by ABTS ................................................................................. 45 
3.3.6 Detection methods ..................................................................................................... 45 
3.3.7 Isotope analysis to evaluate (competing) transformation mechanisms ..................... 46 
3.4 Results & Discussion ........................................................................................................... 47 
3.4.1 Phototransformation .................................................................................................. 47 
3.4.2 Ozonation .................................................................................................................... 48 
3.4.3 Insights into oxidation mechanisms – ABTS & MnO2 .................................................. 49 
3.4.4 Environmental Significance ......................................................................................... 52 
3.4.5 Acknowledgements ..................................................................................................... 54 
3.4.6 References................................................................................................................... 54 
4 Enantioselective Stable Isotope Analysis (ESIA) of Polar Herbicides .......................................... 58 
4.1 Abstract ............................................................................................................................... 59 
4.2 Introduction ........................................................................................................................ 59 
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
  
4.3 Experimental ....................................................................................................................... 61 
4.3.1 Compounds and chemicals ......................................................................................... 61 
4.3.2 Derivatisation with BF3 ............................................................................................... 61 
4.3.3 Isotope Analysis .......................................................................................................... 61 
4.3.4 Calculation of the introduced methyl-group .............................................................. 62 
4.3.5 Peak identity ............................................................................................................... 63 
4.3.6 DCPP transformation study ......................................................................................... 63 
4.4 Results ................................................................................................................................. 64 
4.4.1 Chromatographic Resolution ...................................................................................... 64 
4.4.2 Isotope Analysis .......................................................................................................... 65 
4.4.3 Application of ESIA to phenoxyacids ........................................................................... 67 
4.5 Outlook................................................................................................................................ 68 
4.6 Acknowledgements ............................................................................................................. 68 
4.7 Reference ............................................................................................................................ 69 
5 General Conclusions ................................................................................................................... 71 
Appendix .............................................................................................................................................. I 
Appendix A1. Compound-Specific Isotope analysis of benzotriazole and its derivatives ........... II 
Appendix A2. Combined Isotope and Enantiomer Analysis to Assess the Fate of Phenoxy Acids 
in a Heterogeneous Geologic Setting at an Old Landfill .................................... XVII 
Appendix A3. Supporting Information of Chapter 2 ............................................................... XXXI 
Appendix A4. Supporting Information of Chapter 3 ................................................................ XLII 
Appendix A5. Curriculum Vitae ................................................................................................... L 
 
  
  
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
  
 
ACKNOWLEDGEMENTS 
An erster Stelle möchte ich mich bei Martin Elsner bedanken! Du hast immer die perfekte Balance 
gefunden mich zu fördern und zu fordern. Durch Dein didaktisches Geschick, hatte ich nie das Gefühl 
beim eigenen Unvermögen erwischt worden zu sein, sondern mich immer gefreut was gelernt zu haben! 
Auch weiß ich die große Freiheit zu schätzen mit der ich meine Ideen (und Utopien) ausprobieren durfte, 
immer mit dem Wissen dass Deine Tür offen ist. Vielen Dank! 
Bedanken möchte ich mich auch bei allen Co-Autoren, insbesondere aber bei Carsten Prasse! Deine 
wissenschaftliche Leitlinie „Wenn Leute lachen, sind sie fähig zu denken“ deckt sich zu 100% mit 
meinem Verständnis von Forschung und das große Kino in Kapitel 3 wäre ohne unsere grandiose 
Zusammenarbeit nie gezeigt worden.  
Ein großes Dankeschön geht auch an meine externen Betreuer – Christian Zwiener, Thomas Ternes und 
Michael Radke. Ohne die „Motivation“ aus dem Treffen in Ulm hätten die Diclofenac-Isotope den ngL-1 
Bereich nie gesehen! Außerdem nochmal vielen Dank Michael, hätte die Diplomarbeit bei Dir nicht so 
viel Spaß gemacht, würde es diese Arbeit nicht geben! 
Bei Rainer Meckenstock möchte ich mich herzlich für die Unterstützung und das Vertrauen bedanken, 
das Du mir damals beim Antrag schreiben und der Konzeption dieser Arbeit entgegen gebracht hast. 
Dem ganzen IGÖ, vor allem aber der Isotopenfamilie Danke ich fürs Dasein, für die offenen Ohren, die 
schlauen Kommentare, die gute Laune und Armin für die fränkische Unterstützung im bayrischen Exil – 
Wir sind der Glubb! 
Heini, vielen Dank für die allumfassenden Diskussionen, die immer hilfreich waren die Isotopenanalytik 
im Geschehen des 21. Jahrhunderts sowohl sportlich, wirtschaftlich, wissenschaftlich und auch kulturell 
richtig einzuordnen! Außerdem, vielen Dank für die einmalige Gelegenheit das frisch veröffentlichte 
Kapitel 4 in die große Welt der kommerziellen Isotopenanalyse zu bringen!  
Vielen Dank für die großartige Zeit Thomas Spaett und Sebastian Nitsche! Ihr wart die besten 
Bachelorstudenten die ich je hatte! Mit Euch war „Wissen schaffen und Spaß dabei“ immer Programm!   
Bei der Deutschen Bundesstiftung Umwelt und meinem dortigen Betreuer Max Hempel möchte ich mich  
für die finanzielle Förderung bedanken, vor allem aber auch für die grandiosen Seminare, welche sowohl 
fachlich und sozial ihresgleichen suchen!  
Meiner Familie und insbesondere meinen Eltern und Großeltern möchte ich von ganzem Herzen für die 
Unterstützung Danken! Ohne Euer Vertrauen über all die Jahre wäre diese Arbeit nicht möglich 
gewesen! 
Vielen lieben Dank Tine! Wann immer mich die Massen Spektrometer in den Wahnsinn getrieben 
haben, hast Du mich durch Dein Zuhören und vor allem durch Deine Liebe wieder zurückgeholt – was 
wäre ich ohne Dich! Vielen Dank! 
  
  
  
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
  
ZUSAMMENFASSUNG 
Arzneimittel und Pestizide gelangen über Kläranlagen und Felder in die Umwelt und zählen zu den 
am häufigsten nachgewiesenen Spurenstoffen in Gewässern. Es besteht daher großes Interesse 
herauszufinden, in welchem Ausmaß und durch welche Prozesse Spurenstoffe in der Umwelt abgebaut 
werden können. Allerdings ist es häufig schwierig, Abbauprozesse allein durch 
Konzentrationsmessungen zu bestimmen, da beispielsweise auch Verdünnungsprozesse zu einem 
Rückgang der Konzentrationen führen können. Dabei wird allerdings die Menge an Spurenschadstoffen 
in der Umwelt nicht reduziert, sondern nur ihre Gegenwart verschleiert. Außerdem können durch die 
Konzentrationsmessung von Spurenschadstoffen keine Abbauprozesse unterschieden werden. Dies ist 
zwar durch die Analyse von Transformationsprodukten (TPs) möglich, jedoch sind diese häufig nicht 
vollständig bekannt und können weiter abgebaut werden. Außerdem führen in manchen Fällen mehrere 
Prozesse zu demselben Abbauprodukt. Daher eignen sich bestehende Methoden nur bedingt zur 
(quantitativen) Untersuchung von Abbauprozessen in realen Systemen.  
Komponentenspezifische Isotopenanalyse (CSIA) kann Transformationsprozesse unabhängig von 
Verdünnungseffekten nachweisen und sogar verschiedene Transformationsmechanismen 
unterscheiden. Dabei werden die natürlicherweise im Molekül enthaltenden Isotopenverhältnisse von 
13C/12C und 15N/14N analysiert. Solange kein Abbau stattfindet, sind diese charakteristisch für die 
Herkunft eines Stoffes. Findet Abbau statt, so ändern sich die Isotopenverhältnisse im Substrat in 
Abhängigkeit vom zugrunde liegenden Reaktionstyp. Durch die alleinige Analyse der 
Isotopenverhältnisse des Substrats ist es dann möglich, Abbauprozesse zu untersuchen. Bisher mit 
diesem Ansatz allerdings noch nie Arzneimittel untersucht und außerdem war seine Anwendung auf 
relativ hohe Konzentrationen beschränkt. Daher wurde erstmals eine CSIA Methode für die 
Modellsubstanz Diclofenac entwickelt, welche sowohl in der Medizin, als auch in der Umwelt zu den am 
weitesten verbreiteten Arzneimitteln zählt. Diese neu entwickelte Methode wurde einerseits genutzt 
um die Anwendung von CSIA in den ng L-1 Bereich vorzuspuren. Andererseits wurde sie eingesetzt um 
durch CSIA von Kohlenstoff- und Stickstoffisotopen neue Erkenntnisse auf drei Ebenen zu erhalten.  
(i) Da Isotopenverhältnisse durch die Wahl der Rohstoffe und des Synthesewegs beeinflusst 
werden konnten die meisten der getesteten Diclofenac Produkte (Tabletten, Gele) durch C und N 
Isotopenanalyse unterschieden werden. Dadurch können einerseits pharmazeutische Produkte mit einer 
  
fälschungssicheren Methode verifiziert werden. Andererseits können verschiedene Quellen von 
Diclofenac in der Umwelt verfolgt werden, wie zum Beispiel Kläranalagen oder Gülle von Tieren, welche 
mit Diclofenac behandelt wurden.  
(ii) CSIA konnte als neue Beweislinie für Abbauprozesse etabliert werden, welche unabhängig von 
der Detektion von TPs ist. Sechs verschiedene Transformationspfade wurden untersucht und alle 
konnten durch CSIA nachgewiesen werden. Dabei zeigte sich das interessante Bild, dass sich 
umweltrelevante Reaktionen durch die Analyse der C und N Isotopenverhältnisse in 2 Gruppen 
unterteilen lassen. Während Ozonierung und Photolyse inverse N-Isotopeneffekte verursachen, zeigen 
biologischer Abbau und Abbau durch Manganoxide normale N-Isotopeneffekte. Dies ist einerseits von 
großem Interesse, da sowohl Photolyse als auch biologischer Abbau als potentiell wichtigste 
Eliminationspfade in der Umwelt gelten und CSIA beide Prozesse in-situ unterschieden kann. 
Andererseits kann CSIA auch wertvolle Einblicke in die (Abwasser-) Aufbereitung liefern, wenn die 
Effizienz von biologischer Reinigung, Mangandioxid-Zugabe und/oder Ozonierung untersucht werden 
soll.  
(iii) Dadurch, dass Isotopeneffekte Übergangszustände von Transformationsreaktionen 
widerspiegeln, liefern sie einzigartige Einblicke in Reaktionsmechanismen, welche durch andere 
Methoden unter umweltrelevanten Bedingungen nicht zugänglich sind. Das damit einhergehende 
Potential von CSIA wurde beim Vergleich der Reaktionen von Diclofenac mit MnO2 und ABTS deutlich. 
Beide Reaktionen wurden als Modelle für Ein-Elektron-Oxidation angesehen, welche häufig bei 
enzymatischen Reaktionen auftritt. Allerdings zeigte CSIA, dass sich beide Reaktionen fundamental 
unterscheiden. Während ABTS tatsächlich durch Outer-Sphere-Ein-Elektron-Oxidation reagiert und 
inverse N-Isotopeneffekte verursacht, zeigte sich bei MnO2 ein ausgeprägter normaler N-Isotopeneffekt 
der zudem mit dem Fraktionierungsmuster des biotischen Abbaus übereinstimmt. Ferner wurde durch 
CSIA deutlich, dass die ausgeprägte Isotopenfraktionierung einen wichtigen, aber noch unerforschten 
Transformationspfad widerspiegelt, welcher momentan nicht durch Transformationsprodukte 
detektierbar ist. Als weitere wichtige Reaktion Außerdem wurden mittels CSIA zum ersten Mal  
Transformationsprozesse bei der Ozonierung studiert. Dabei lieferte CSIA ein starkes Indiz dafür, dass 
das Ozonmolekül nicht am N-Atom von Diclofenac angreift, sondern am aromatischen Ring.  
Neben Diclofenac wurden im Rahmen dieser Arbeit auch chirale Herbizide untersucht. Dazu wude 
CSIA mit enantioselektiver Trennung kombiniert um die Transformationsprozesse von chiralen 
Herbiziden mit einem noch vielfältigeren Ansatz zu untersuchen. Es zeigte sich, dass Isotopen- und 
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Enantiomerenverhältnisse komplementär verhalten. Während in dieser Studie ein Fall untersucht 
wurde, bei dem keine Isotopenfraktionierung, allerdings Enantiomerenfraktionierung gemessen werden 
konnte, wurde in einer anderen Studie genau das Gegenteil für ein Insektizid beobachtet. 
Interessanterweise konnten in einer ersten Feldstudie beide Prozesse parallel nachgewiesen werden.    
Die vorliegende Studie hat gezeigt, dass CSIA und ESIA in vielfältiger Weise dazu beitragen 
können, den Abbau von Spurenschadstoffen in der Umwelt zu untersuchen und vor allem besser zu 
verstehen. Für Diclofenac wurde exemplarisch aufgezeigt, dass Isotopenanalyse einzigartige Einblicke in 
das Transformationsverhalten von Arzneimitteln geben kann. Es kann besteht daher großes Potential die 
in dieser Studie vorgestellte Methodik auf eines der anderen 10.000 Arzneimittel zu übertragen, welche 
momentan auf dem Markt sind. Auch im Bereich der chiralen Isotopenanalyse (ESIA) gibt es noch 
unbegrenzte Möglichkeiten. Neben der Analyse weiterer Pestizide haben nicht zuletzt die Ergebnisse für 
Diclofenac gezeigt, dass die Analyse eines zweiten Elements (H oder N) den Erkenntnisgewinn 
vervielfachen kann. Außerdem liegt die Möglichkeit auf der Hand ESIA auch auf chirale Blockbuster-
Arzneimittel, wie z.B. Ibuprofen oder Metoprolol, anzuwenden.  
  
 
SUMMARY 
Pharmaceuticals and pesticides are among the most frequently detected micropollutants in 
natural waters because they enter the environment via sewage treatment plants or by application to 
fields. Hence, it is of great interest to know if they can be degraded in the environment and by which 
processes. However, the complexity of aquatic systems makes it challenging to assess the environmental 
fate of micropollutants by concentration measurements, because concentrations are not only affected 
by degradation, but also by dilution processes. In addition, concentration analysis cannot distinguish 
transformation processes and their underlying reaction mechanisms. To some part this can be achieved 
by the analysis of transformation products (TPs), but they are often not fully elucidated, can be further 
degraded and in some cases different reaction mechanisms yield the same transformation product. 
Compound specific isotope analysis (CSIA) is an elegant alternative that is independent of dilution 
and can even deliver insights into reaction mechanisms. This approach is based on the detection of 
stable isotopes of C (13C/12C) and N (15N/14N) which are an inherent trait of all organic substances. In the 
absence of transformation processes, isotope ratios are preserved and can be used to verify the origin of 
substances. If transformation takes place, isotope ratios of the substrate are shifted and the magnitude 
of this shift is determined by the reaction mechanism. Consequently, transformation reactions can be 
directly detected by isotope analysis of the substrate and the magnitude of fractionation can deliver 
insight into the underlying mechanism. Before this thesis was initiated the applicability of CSIA was 
limited to relatively high concentrations and isotope fractionation of pharmaceuticals during 
transformation reactions was unexplored territory. Hence, the present thesis developed for the first 
time compound specific isotope analysis (CSIA) for a pharmaceutical, using diclofenac as a model 
compound, which is one of the most frequently consumed pharmaceuticals, but also among the most 
frequently detected micropollutants in the environment. First, this method was used to demonstrate its 
applicability to the ng L-1 range, which makes it one of the most sensitive CSIA methods at all. 
Subsequently, CSIA was used to gain insights about its fate on three levels.  
(i) Since isotope ratios are determined by the resources used in synthesis and the synthesis 
pathway, the analysis of C and N isotope ratios could distinguish most of the tested commercial 
diclofenac products (tablets, gels). On the one hand this finding can be used to verify commercial 
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products with a fraud-resistant method. On the other hand this approach can be extended to distinguish 
sources of diclofenac in the environment, such as sewage treatment plants or manure that originates 
from diclofenac treated cattle. 
(ii) CSIA could be established as a new line of evidence for transformation that is independent of 
TP analysis. Six transformation pathways were investigated and all of them could be tracked by CSIA. 
Moreover, the remarkable picture was obtained that all tested environmentally relevant transformation 
reactions can be separated into two groups that can be distinguished from each other by the analysis of 
C and N isotope ratios. Ozonation and photolysis cause inverse isotope fractionation, whereas 
biotransformation and MnO2 lead to normal isotope fractionation. This is of great interest for 
environmental investigations, since photolysis and biotransformation are discussed as the two most 
important transformation pathways in the environment and CSIA delivers a direct measure for their 
relative importance. But CSIA can also provide insights into engineered systems, because it can be used 
to investigate the efficiency of biotransformation and / or ozonation during (waste-) water treatment. 
(iii) Because isotope effects mirror transition states of transformation reactions, they deliver 
unique insights in reaction mechanisms that cannot be obtained by other methods under 
environmentally relevant conditions. The big potential of this approach became apparent when 
transformation by ABTS and MnO2 was compared. Both processes are supposed to mimic single electron 
oxidation (SET), which is proposed to be of big importance in enzymatic transformation reactions. CSIA 
revealed that ABTS is indeed a model for SET. In contrast, MnO2 showed a completely different isotope 
fractionation that was at the same time in perfect agreement with aerobic biotransformation.  
Moreover, it was strongly indicated that the observed isotope fractionation during MnO2 or 
biotransformation, points towards an overseen transformation pathway that can only be seen by CSIA at 
the moment. Furthermore, CSIA was applied for the first time to study transformation processes during 
ozonation. There, it provided evidence that ozone rather attacks at the aromatic ring of diclofenac than 
at the N-atom. 
 (iv) Besides CSIA of diclofenac, the present thesis investigated also chiral herbicides. CSIA was 
combined with enantioselective separation to yield enantioselective an even more versatile approach – 
enantioselective stable isotope analysis (ESIA). ESIA was used for the first time to investigate the fate of 
the chiral herbicides and revealed that isotope ratios and enantiomeric ratios behave complementarily. 
In this thesis a case was studied were pronounced enantiomer fractionation, but no isotope 
fractionation was detected, while the opposite was found for an insecticide in another study. When ESIA 
  
was brought to the field results were even more fascinating, because isotope- and enantiomeric 
fractionation were observed simultaneously.  
The present thesis could demonstrate that CSIA and ESIA can improve our understanding of 
micropollutant transformation in the environment in several ways. There is great potential when the 
methodology of this dissertation will be applied to one of the other 10,000 pharmaceuticals that are on 
the market. But also the novel area of ESIA offers plenty of possibilities, when this approach will be 
transferred to other pesticides and processes. Even more exciting, ESIA of carbon can be combined with 
the analysis of nitrogen or hydrogen and this would increase the knowledge gain dramatically as shown 
for CSIA of diclofenac. Moreover, ESIA should not be restricted to pesticides, but this approach urges to 
be extended to chiral pharmaceuticals, such as ibuprofen or metoprolol. 
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1.1 Global challenges related to pesticides & pharmaceuticals 
Pesticides and pharmaceuticals increased our living standard substantially by improving crop 
yields and curing diseases, respectively. However, both compound classes have in common that after 
application their residues end up in the environment as micropollutants and constitute a potential 
threat to human and environmental health.1, 2  
1.1.1 Occurrence of Micropollutants in the Environment 
Micropollutants enter the environment via different pathways. The most obvious pathway is the 
direct application of pesticides to fields and it is estimated that between 1 and 2.5 million tons of 
pesticides are used in agriculture every year.3 After their application, pesticides can be (partially) 
degraded, but they can also enter the water cycle via surface runoff or by leaching into groundwater.1, 4 
However, micropollutants can also indirectly enter the environment. One pathway is the consumption 
of pharmaceuticals by humans. After incomplete transformation in the human body,5 pharmaceuticals 
reach sewage treatment plants where they are only incompletely eliminated and subsequently emitted 
into receiving waters.6, 7 To illustrate the importance of this pathway one can, for example, look at the 
pharmaceutical consumption of Germany. In total 31,000 t of active pharmaceutical ingredients are 
consumed per year8 and 328 human pharmaceuticals were applied at an amount higher than 5 t a-1.9 
This number does not include pharmaceuticals like ethinyl estradiol that are consumed at a lower level 
(0.05 t), but have by definition an endocrine effect on organisms.9 The second pathway concerns 
veterinary pharmaceuticals. After application they are excreted and distributed to fields as manure, 
which is used as fertilizer.2, 10 Many of these veterinary pharmaceuticals, such as the anti-inflammatory 
agent diclofenac, are also applied to humans. Nevertheless, the veterinary pathway is special, because in 
analogy to pesticides it brings pharmaceuticals directly into the environment without passing a sewage 
treatment plant, where they could be at least be partially degraded. Both classes of micropollutants, 
pesticides and pharmaceuticals, have in common that their occurrence in the environment is abundantly 
documented, but their fate (distribution / further degradation) remains incompletely understood.  
1.1.2 Effects & Fate of Micropollutants in the Environment 
Knowledge about the self-cleaning potential of ecosystems is not only of scientific value, but 
affects everyone, since clean water is the basis of human- and environmental health. The necessity of 
terminal elimination is not only given for pesticides, which are harmful to biota by definition. 
Pharmaceuticals should neither be present in the environment. Besides the precautionary principle - 
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their longterm (eco-) toxicity is largely unknown - some candidates were shown to have ecotoxicological 
effects at their present level in the environment.2, 11 For example, the pain-killer and anti-inflammatory 
agent diclofenac was shown to cause kidney damages in fish or inhibit mussel growth.11-14 Moreover, it 
caused a drastic decrease in Indian vulture populations, because the vultures preyed cattle, which was 
treated with this anti-inflammatory agent.12, 15  
The fate of micropollutants can be influenced by various processes. They can be adsorbed, 
diluted, transformed, finally be degraded or behave in a persistent way.1, 2, 4 Among these processes only 
degradation – sometimes transformation to daughter products, in the best case mineralization to H2O 
and CO2, ensures that micropollutants do not accumulate in the environment. Depending on their 
structure, micropollutants can be transformed by: abiotic hydrolysis, (a)biotic oxidation, (a)biotic 
reduction or phototransformation. As a general trend, biodegradation and phototransformation often 
play the dominant role.4 Nonetheless, the efficiency of these processes has to be assessed for each 
substance and each site individually. This can be illustrated at the example of diclofenac. Several studies 
could show in laboratory experiments that sunlight can efficiently transform diclofenac within hours. In 
contrast, river water/sediment batch studies have to be conducted for days to observe pronounced 
transformation. Therefore, it is difficult to extrapolate such findings from lab to field scale. On the one 
hand photo-transformation is often less efficient in the field due to turbidity, duration and intensity of 
sunlight or deep water bodies. On the other hand it was shown that biodegradation can be very efficient 
in flow-through-columns (half life time = 0.6 d) and turnover rates strongly depend on the exchange 
between a water body and the hyporheic zone. Consequently, robust methods are demanded to assess 
the self-cleaning potential of ecosystems. 
1.1.3 Established Techniques to Investigate the Fate of Micropollutants 
In laboratory experiments, micropollutant transformation is typically studied by measuring a 
decrease in concentrations over time. However, such an approach is difficult to pursue in natural 
systems, because concentrations are not only affected by transformation, but also by other processes, 
such as dilution or adsorption.4 These processes do not lower the load of micropollutants in ecosystems, 
but camouflage their presence. To distinguish them from transformation, concentration measurements 
need to be accompanied by the application of conservative tracers and/or hydrological modeling.16 
Alternatively, transformation products (TPs) can be detected as direct proof for transformation.17-19 
However, TPs can only be detected if they are at least meta-stable, do not immediately adsorb to humic 
substances and they must be detectable by the applied analysis technique. Moreover, a quantitative 
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interpretation of TP data is not only challenging due to their further transformation, but also due to a 
lack of reference standards that are needed for their quantification by mass spectrometry. Hence, it is 
often not possible to estimate the extent of transformation of the original micropollutant by the analysis 
of its TP.17, 20-22 Consequently, additional tools are needed that circumvent the limitations of 
concentration analysis and the detection of TPs to obtain a comprehensive picture of micropollutant 
transformation in the environment. 
1.1.4 Product Counterfeiting of Pharmaceuticals 
Innovative analytical techniques are not only demanded to characterize transformation of 
pharmaceuticals in the environment, but also to verify their origin and to protect intellectual property. 
The IFPMA (International Federation of Pharmaceutical Manufacturers Association) assumes that 
currently 7% of all pharmaceuticals are non-genuine, and the relevance of counterfeit products is 
increasing.23 This is an issue of global concern with an estimated economic loss of 75 billion US$ per 
year.24 Besides products that do actually not contain the appropriate agent and are easy to detect when 
subjected to analysis, there is an increasing number of fakes which contain the chemically equivalent 
active agent in the appropriate dose.23 In such cases conventional analysis must rely on the possible 
presence of different byproducts (“chemical fingerprinting”), or else there is no chance to identify a 
faked product.  
1.2 Principles of Enantioselective & Compound Specific Isotope Analysis 
(ESIA & CSIA) 
The analysis of stable isotope ratios (e.g. 13C/12C) has unique advantages and can address the 
research gaps of micropollutants from a new angle. CSIA can track the origin of products and sources 
(1.2.1), detect transformation processes (1.2.2) and investigate transformation mechanisms (1.2.2). To 
this end isotope ratios are usually reported in the delta notation (Eq. 1-1, 1-2). Isotope ratios that are 
determined on one specific instrument (12C/13CSample , 
15N/14NSample) are referenced to an internationally 
accepted standard (12C/13CReference ,
15N/14NReference). This reference material is Vienna PeeDee Belemnite for 
C and air for N. Consequently, values can be compared even if instrument performance differs between 
instruments or laboratories.25 
      
(            
                  
  )
              
   (1-1) 
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1.2.1 Source Tracking of Micropollutants by CSIA 
Looking from a broader perspective at the natural abundance of light and heavy isotopes of C and 
N, they seem to be constant (Tab. 1-1). However, modern isotope ratio mass spectrometry (IRMS) allows 
having a closer look on these ratios. In fact, high precision isotope analysis can reveal differences in the 
isotopic signature of a certain compound depending on its origin.26, 27 For example, isotope ratios were 
used to distinguish original insecticide products from fakes28 and delivered insight if caffeine in drinks is 
of natural or synthetic origin.29 For pharmaceutical products such as aspirin, ibuprofen or naproxen, it 
has been shown that the analysis of stable isotope ratios of selected elements (e.g. 13C/12C or 15N/14N) 
can be used as a fingerprint for product authentication. In one case it was even possible to determine 
the location of an illegal production site by isotope analysis.24 
All these studies were based on the fact that differences in a certain production process are often 
reflected by isotope ratios. This is possible, because isotope ratios are determined by two factors. The 
first factor is the isotope ratio of the educts. This ratio is passed on to the product, provided that 
conversion is 100%. The second factor is the isotope effect of the commercial synthesis, which becomes 
important if conversion is not 100%. The underlying mechanism is called kinetic isotope effect (KIE) and 
described in 1.2.2. . Briefly, KIE describes that molecules which carry a light isotope at the reactive 
position often differ in reaction speed in comparison to molecules with a heavy isotope.30, 31 For 
example, the heavier isotopologue (e.g. molecule containing 13C) could react preferentially to a by-
product, while the lighter isotopologue (12C) ends up preferentially in the final product. The final product 
would then show a lighter isotope ratio than its educt(s) and the by-product would be heavier. Hence, 
isotope ratios can be used to prove the authenticity of (proprietary) substances, because synthesis 
pathways and isotope ratios of the educts often differ among producers and especially between 
companies and (low-budget) counterfeiters.26-28 Moreover, in the absence of transformation processes 
isotope ratios behave conservative. This means that processes, such as dilution do not alter isotope 
ratios and as long as a compound is not transformed, it keeps its original isotopic fingerprint.30 
Consequently this approach is not restricted to industrial applications, but can also serve for source 
tracking of contaminants in the environment.32, 33   
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However, existing methods for isotope analysis of pharmaceuticals have limited applicability. 
Isotope ratios of several elements can be analyzed with high precision, if elemental analysis is coupled 
to isotope ratio mass spectrometry (EA-IRMS). However, it is necessary to extract large amounts of the 
active pharmaceutical ingredient (API) out of a formulation, which is very laborious and time 
consuming.26, 27. This can be circumvented by the coupling of liquid chromatography to IRMS (LC-IRMS). 
LC-IRMS can separate API from other ingredients automatically, but in return it is restricted to the 
analysis of carbon isotopes.34, 35 Gas chromatography coupled to IRMS (GC-IRMS) would allow an 
automatic separation of ingredients, deliver an excellent quantification limit for precise isotope analysis 
and offers the possibility to analyze isotope ratios of C, N, H and O.25 However, to date there is no 
method available to analyze isotope ratios of pharmaceuticals by GC-IRMS. 
Tab. 1-1. Isotope abundance of C and N and the precision of GC-IRMS (gas chromatography - isotope 
ratio mass spectrometry). Adopted and modified from Elsner et al.
25
. 
Element Natural abundance of 
the lighter isotope 
Natural Abundance 
of heavier isotope 
Typical precision of GC-IRMS 
(variation in the isotope ratio) 
Carbon (12C, 13C) 98.9% 1.1% 0.5‰ 
Nitrogen (14N, 15N) 99.6% 0.4% 1.0‰ 
 
1.2.2 Isotope Fractionation during Transformation Reactions 
Isotope ratios are an inherent and unique feature of substances that can be used to investigate 
reactions. The underlying principle is the kinetic isotope effect (KIE). The KIE describes the phenomenon 
that usually molecules carrying a lighter isotope at the reactive position need less activation energy than 
molecules with a heavy isotope (Fig. 1-1a).30, 31 Hence, in most cases lighter isotopes are faster 
transformed.36  
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Fig. 1-1. Difference in vibrational energies between light and heavy isotopes during a transformation 
reaction; a) in most cases light isotopes need less activation energy (Elight)  than heavy isotopes (Eheavy) to 
reach the transition state and the remaining reactant gets enriched in heavy isotopes; b) if bonds are 
stiffer in the transition state (larger force constant in comparison to ZPE) the transformation product get 
enriched in heavy isotopes 
This phenomenon can be explained by looking at the four different types of bond energies:  
electron energy, vibrational energy, translational energy and rotational energy. Although electron 
energy is the strongest bond energy, it does not play a role for isotope effects, because electron 
movement is not influenced by the nuclei-mass (Born-Oppenheimer Approximation).36 However, there 
are three mass-dependent types of bond energies. Among these, vibrational energy is much more 
important than translational- or rotational energy. Molecules vibrate even at the lowest energy level, 
the so called zero point energy level (ZPE), which corresponds to 0 K.36 If energy is added to a molecule, 
its vibrational energy can change in discrete steps. Looking at the vibrational energy levels of two 
isotopes, it becomes apparent that the ZPE of the heavier isotope is lower than the ZPE of the lighter 
isotope (Fig. 1-1).36 If two isotopes undergo the same transformation reaction the heavier isotope 
requires more activation energy. Hence, in most cases lighter isotopes are faster transformed (Fig. 1-1a). 
22, 23 This leads to an enrichment of heavy isotopes on the reactant side, while transformation products 
show a lighter isotope ratio (normal isotope effect). In some cases the bonds are stronger in the 
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transition state (larger force constant) than at ZPE (Fig. 1-1b).37, 38 This means that the difference in 
vibrational energy between two isotopes is larger in the transition state in comparison to the ZPE. 
Consequently, the lighter isotopes need more activation energy and react slower. This leads to 
isotopically lighter reactants and heavier transformation products (inverse isotope effect). Based on this 
concept isotope analysis of the reactant can deliver insight into reaction mechanisms, even if TPs cannot 
be detected. At the same time isotope ratios give us the opportunity to catch a glimpse on rate-limiting 
transition states of reactions, which is not possible by concentration measurements or TP analysis 
(Fig. 1-2). 22, 23 
Fig. 1-2. While concentration analysis is restricted to the observation if reactants decrease or not, isotope 
ratios of the reactant reflects the transition state of a transformation reaction, even if no transformation 
products can be detected 
Interestingly, the kinetic isotope effect is not restricted to a qualitative interpretation, but can 
also be used to quantify transformation. Looking at two sampling events (0, t), there is a direct 
correlation between the extent of transformation (f = Ct / C0) and the change in isotope ratios (
13C0, 
13Ct) (Eq. 1-3).
 22, 23 
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 The linking parameter is the enrichment factor ε, which is characteristic for specific reactions and 
specific elements. ε bears the information about the transition state as discussed above. If ε < 0 light 
isotopes react faster (normal isotope effect) and if ε > 0 heavy isotopes react faster (inverse isotope 
effect). Since Eq. 1-3 consists of four parameters (δ13Ct, δ
13C0, ε, f) it is sufficient to determine three 
parameters and calculate the fourth one. Hence, ε can be determined in the lab, where concentrations 
and isotope ratios can be analyzed in a closed system. Subsequently, it is possible to analyze isotope 
ratios in the field. With knowledge of three parameters (epsilon, δ13Ct, δ
13C0) it is then possible to 
determine the extent of transformation f.39 
As described in 1.2.4 isotope ratios of micropollutants need to be analyzed by GC-IRMS to achieve 
maximum sensitivity. Unfortunately, this approach relies on the combustion of the target analyte to CO2 
and/or N2. This means that site-specific information about isotope enrichment is lost during combustion 
and the intrinsic isotope effect of the reacting position is diluted by all the other atoms of the same 
element that were not involved in the reaction. Hence, measured isotope enrichment needs to be 
corrected for the overall number of atoms of one element (n)(Eq. 1-4).31 This calculated isotope effect of 
the reactive position is called position-specific kinetic isotope effect (KIE). 
                  (1-4) 
 The intrinsic KIE may be masked through the presence of additional rate-limiting steps, such as 
adsorption to reactive surfaces in abiotic reactions or transport limitations in biological reactions. 
Therefore, measured isotope effects are usually stated as apparent kinetic isotope effect (AKIE), which 
implies that it could be smaller than the intrinsic KIE.30, 31 The calculation of AKIE is important to 
recognize similarities or differences in the reaction mechanism of compounds that differ in n.  
1.2.3 Principles of Enantioselective Isotope Analysis (ESIA) 
Many natural and synthetic molecules contain at least one chiral center.40, 41 In a similar way as 
human hands, they occur in two modifications that behave like mirror-images of each other and are 
called enantiomers.42 Just as isotopologues, enantiomers share most chemical properties and cannot be 
separated easily.42 However, the behavior of two enantiomers differs in terms of stereochemistry. This is 
of special importance in enzymatic reactions where reactivity depends strongly on the three 
dimensional structure of an enzyme and its substrate.43 Hence, if enzymes are involved, enantiomers 
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often differ in reaction kinetics, bioavailability or toxicity.40, 44-46 There are two important processes that 
directly affect the ratio of two enantiomers. On the one hand enzymes can prefer one enantiomer over 
the other during transformation, which leads to a faster depletion of this enantiomer (Fig. 1-3).41 On the 
other hand enzymes for active transport into cells can also be enantioselective.47 This can speed up the 
transport of one enantiomer into a cell where it is transformed by other enzymes (Fig. 1-3). Because 
these processes cause a shift in the ratio of two enantiomers, they can be tracked by enantioselective 
analysis. Since enantiomer analysis detects molecular ratios in a similar way as isotope analysis, it is also 
not influenced by dilution effects and may represent a similarly robust measure for transformation. At 
the same time, enantiomer analysis can be expected to be complementary to CSIA. Specifically, 
enantiomer fractionation can occur if active transport into cells is enantioselective and rate-determining 
(Fig. 1-3). This is a situation where evidence from isotope fractionation would be inconclusive, because 
no bonds are broken or formed during transport and, hence, no isotope effects would be expected. Vice 
versa, isotope fractionation may be detected if enzyme transformation is rate-determining, but not 
enantiomer-specific – a case where enantiomer analysis would be inconclusive. 
Fig. 1-3. Depending on the rate-determining step two enantiomers (blue pentagon, red hexagon) can be 
discriminated during (a) enzymatic transformation or (b) active transport into cells; note that in case b) no 
isotope fractionation would occur, because no bonds are cleaved in the rate determining step  
To communicate changes in enantiomeric ratios two equal notations have been established – 
enantiomeric excess and enantiomeric fraction.40, 48 In this study enantiomeric fraction (EF) is used, 
b) Uptake is rate-determining and enantioselective
a) Transformation is rate-determining and enantioselective
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where the ratio of the R (Eq. 1-5) or the S enantiomer (Eq. 1-6) is expressed as percentage of the total 
concentration of the racemate [EFR, EFS]. Nearly all commercial products have either an EF of 0.5 
(racemates) or 0 (enantio- pure products).  
    
   
       
 (1-5) 
    
   
       
 (1-6) 
1.3 Content of the present thesis 
CSIA and ESIA have the potential to tackle the grand challenges of micropollutants in the 
environment: to distinguish their sources, to proof their transformation and to investigate their 
transformation mechanisms. To this end five major challenges have to be mastered. In the present this 
was done in Chapter 2 and 3, where CSIA was used for the first time to investigate the fate of 
pharmaceuticals - using diclofenac as a model compound - and in Chapter 4 where ESIA was applied for 
the first time to herbicides.  
1.3.1 Analytical Challenges & Objectives of CSIA and ESIA of Micropollutants  
(i) The most obvious challenge is of analytical nature and concerns the literally low concentration 
range of micropollutants. Theoretically this holds true for all analytical techniques. For CSIA it is even 
more difficult, because conventional mass spectrometry usually analyzes the most abundant isotope. 
CSIA, in contrast, must also analyze the heavier isotope, which is by far less abundant. In case of carbon 
this leads to an increase of the detection limit by a factor of 100 (~1% 13C in Ctotal). For nitrogen this limit 
increases even by a factor of 600, because in addition to the low proportion of 15N (~0.3% of Ntotal) two N 
atoms are needed to create one molecule of analyte gas (N2).
25 Because the minor isotope must be 
determined with a very high precision, the real limits are even higher as described in Elsner et al.25. 
Hence, effective pre-concentration steps are needed in combination with the most sensitive analytics. 
To this end the limit of precise isotope analysis was determined Chapter 2 by combining a solid phase 
extraction, clean-up by preparative HPLC, derivatization and on column injection, which is the most 
sensitive injection technique. 
(ii) As stated above, the use of gas chromatography coupled to IRMS mandatory when highest 
sensitivity is needed for CSIA of micropollutants.25 During gas chromatography target analytes have to 
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be combusted without decay to pass through the chromatographic column. However, many 
micropollutants are at least semi-polar, because they carry a carboxyl- and/or an amine group. This 
causes a high boiling point, a high retention due to exchangeable hydrogen atoms and often compounds 
start to decay before they are quantitatively transferred through the gas chromatograph. 
Consequently, sensitive derivatization techniques have to be developed for micropollutants. Because 
derivatization is by definition a chemical reaction where bonds are broken, such a sample preparation 
must be conducted under absolutely controlled condition.49 Otherwise (irreproducible) isotope effects 
during derivatization would impede an evaluation of isotope data.50 Moreover, all common 
derivatization agents introduce at least one carbon atom into the analyte.25, 50 Hence, isotope ratios 
have to be corrected for every introduced C-atom. At the same time these additional C-atoms must have 
a constant isotope ratio to ensure a constant C-isotope shift of all samples and the respective control 
standards that are used for corrections.51 Hence, two derivatization GC-IRMS methods were established 
for diclofenac in Chapter 2 facilitating either quick or sensitive analysis. In addition, the sensitive method 
was transferred to polar herbicides in Chapter 4. 
(iii) For enantioselective isotope analysis a fifth requirement comes into play – the perfect 
separation of enantiomers. However, enantiomers cannot be easily separated, because they share most 
chemical properties. Hence, special separation techniques are demanded. For enantiomers, the use of 
gas chromatography offers the advantage to use an enantioselective column. In these columns analytes 
are not (only) separated by polarity, but also by their stereochemical properties. This concept is already 
known for GC-MS analysis, but again, GC-IRMS has special requirements.44, 45 While in conventional 
analysis a small overlap of enantiomer peaks can be tolerated, this is not possible for GC-IRMS. The 
reason is the chromatographic isotope effect. Within one peak heavy and light molecules are not equally 
distributed, but heavy isotopologues elute at the peak front and light isotopologues elute at the peak 
tail.52 This is caused by van der Waals interactions between analyte and the nonpolar column coating. 
Hence it is essential that each enantiomer peak is perfectly separated (Peakwidth/ (Retention time 
difference between two peaks) >1.5). This is even more challenging when several micropollutants with 
similar structures are present in one sample. One example is the herbicide DCPP, which is often 
detected in the field together with its TP 4-CPP or the herbicide MCPP. All three compounds are 
chlorinated phenoxy acids, share the same chiral center and differ only in one methyl-group or a 
chlorine atom, respectively. Consequently, a sensitive method was established in Chapter 4 that is 
capable of analyzing isotope ratios of each single enantiomer of these herbicidal compounds. 
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1.3.2 Challenge of large number of C-atoms in micropollutants 
The fourth challenge is the large number of C-atoms in most micropollutants. The biggest 
advantage of GC-IRMS is its superior detection limit for precise isotope ratios. However, the low 
detection limit is achieved by burning the target analyte to CO2 and N2 after separation. This yields a 
simple analyte gas that contains only one (dominant) isotope. If only one C or N atom is present in a 
molecule this procedure does not affect the intensity of measurable isotope effects. In cases where 
several atoms of the same element are present in a molecule, isotope enrichment takes only place at 
one position. All other atoms from the same element dilute the measurable effect of this reactive 
position. This lead to the assumption that C-isotope fractionation is not detectable any more, if 
molecules contain more than 14 C-atoms.53 Because the magnitude of fractionation depends on the 
reactant and the reaction type it remains to be investigated, if this also applies for micropollutants that 
are in this range. This challenge was tackled in Chapter 2 and 3 for the painkiller diclofenac (14 C atoms) 
and three herbicides (9 or 10 C atoms) in Chapter 4. 
1.3.3 Challenge of process understanding 
Traditionally, CSIA is applied to contaminants, whose transformation products (TPs) are well 
investigated, such as chlorinated ethenes.54 In this case CSIA is used to elucidate the underlying 
transformation mechanism and applied as a robust measure for transformation in the field. In contrast, 
the mass balance between most micropollutants and their potential TPs is not closed. Hence, even if 
some TPs are known, it is unclear if they represent the quantitatively most important transformation 
pathway. Hence, a mechanistic interpretation of isotope enrichment of micropollutants is rather 
challenging, because the importance of a certain pathway can often not be deduced from TP analysis 
and different pathways can yield the same TP. 
Consequently, Chapter 2 investigated in a first proof of principle study, isotope fractionation of 
aerobic biotransformation and reductive dechlorination. In a comprehensive approach, Chapter 3 
studied the variability of isotope fractionation of diclofenac and it was tested which processes can be 
distinguished from each other by CSIA. To this end phototransformation and ozonation were 
investigated as environmentally relevant processes and transformation by MnO2 and ABTS radicals was 
used to gain deeper insights into the (biotic) oxidation of diclofenac. Moreover, Chapter 4 explored the 
potential of ESIA to obtain mechanistic insight into herbicide transformation. 
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2.1 Abstract 
Although diclofenac is frequently found in aquatic systems, its degradability in the environment 
remains imperfectly understood. On the one hand, evidence from concentration analysis alone is 
inconclusive if an unknown hydrology impedes a distinction between degradation and dilution. On the 
other hand, not all transformation products may be detectable. As a new approach we therefore 
developed GC-IRMS (gas chromatography - isotope-ratio mass-spectrometry) analysis for carbon and 
nitrogen isotope measurements of diclofenac. The method uses a derivatization step that can be 
conducted either online or offline, for optimized throughput or sensitivity, respectively. In combination 
with on-column injection the latter method enables determination of diclofenac isotope ratios down to 
the sub- -1 range in environmental samples. Degradation in an aerobic sediment-water-system 
showed strong nitrogen isotope fractionation (εN = -7.1‰), whereas reductive diclofenac dechlorination 
was associated with significant carbon isotope fractionation (εC = -2.0‰). Hence dual element isotope 
analysis bears potential not only to detect diclofenac degradation, but even to distinguish both 
transformation pathways in the environment. In an explorative survey, analysis of commercial 
diclofenac products showed significant differences in carbon and nitrogen isotope ratios demonstrating 
a further potential to track, and potentially even authenticate, commercial production batches.  
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2.2 Introduction 
Diclofenac is one of the most popular painkillers and anti-inflammatory agents in the world with a 
yearly consumption in Germany, for example, of 86 t.1 On the downside, it enters the environment via 
sewage treatment plants or runoff from fields as a consequence of artificial recharge.2-5 There, it has the 
potential to bioaccumulate in mussels and inhibit their growth6, to harm rainbow trout7,  and it has been 
linked to the eradication of whole vulture populations.8 While its importance is emphasized by the fact 
that the European Union recently proposed to add it to the list of priority pollutants9 the assessment of 
its degradability in the environment remains a major challenge.  
Concentration measurements alone are often inconclusive, because in rivers or groundwater it is 
typically difficult to obtain a closed hydraulic mass balance. To this end the hydrology has to be very well 
understood, including parameters like flow velocity, ex- and infiltration. Without this data it is not 
possible to distinguish between a concentration decrease along a stretch of a river due to degradation 
or due to dilution by infiltrating groundwater.10 In addition, evidence about transformation pathways is 
needed, and also this information is not accessible from concentration measurements alone. 
Transformation products may deliver insight11-14, but in the case of pharmaceuticals many of them are 
unknown and may in addition not be detectable because they are further transformed.11, 13, 15A common 
approach to assess degradation processes is the determination of degradation kinetics and the analysis 
of transformation products in sediment-water tests.15-17 Although they can be used to compare the 
degradation kinetics of different compounds under the same conditions, the results depend strongly on 
the selected setup and sediment.18 Owing to this fact, and due to the heterogeneity of geochemical 
boundary conditions at field sites it is very difficult to extrapolate results from those lab-scale tests to a 
larger scale like a river stretch. 
Compound specific isotope analysis (CSIA) has the potential to provide a new, complementary 
handle to assess degradation of environmental pollutants.19-21 This approach relies on isotope analysis of 
the original contaminant, without the need of metabolite analysis. Isotopes are contained in chemical 
bonds where they are not susceptible to isotopic exchange so that isotope ratios do not change in the 
absence of degradation. If these bonds are broken during (bio)chemical transformation, however, bonds 
with light isotopes typically react slightly faster than bonds with heavy isotopes (kinetic isotope effect, 
KIE).22 Consequently the remaining substrate molecules contain on average increasingly more heavy 
isotopes. This enrichment of heavy isotopes in the original contaminant (as reflected in 13C/12C, or 
15N/14N) may therefore provide an independent line of evidence of its degradation, even if products are 
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not detected. Furthermore, dilution leaves isotope ratios unaffected, while it can cause false positives in 
assessments based on concentration data.23 Therefore, degradation can be investigated even if the 
hydrological mass balance is not closed and data interpretation does not depend on hydrological 
investigations such as tracer tests. As additional virtue, CSIA can deliver even insight into reaction 
mechanisms if isotopes of two or more elements are analyzed.22 The reason is that different (bio-) 
chemical reactions involve specific bonds containing different elements so that isotope effects are 
observed specifically for those elements in the bond that is reacting. Previous work on isoproturon, 
atrazine, and BAM24-27 has shown that isotope analysis of two elements (two-dimensional isotope 
analysis) has the potential to elucidate different transformation pathways of pesticides. However, to 
date there is no study available about the investigation of pharmaceutical degradation by CSIA. 
The first aim of the present study was, therefore, to establish a GC-IRMS method for diclofenac 
that can serve as a tool to distinguish degradation pathways by analyzing carbon and nitrogen isotope 
values. To this end a method was developed that features an online- or offline-derivatization step, 
depending on whether fast or sensitive analysis is required. The second aim was to investigate isotope 
fractionation in two degradation test systems. This proof of principle study was conducted (a) in an oxic 
sediment-water-system to assess isotope fractionation under environmentally relevant conditions and 
(b) for reductive dechlorination under reducing conditions. To investigate the potential for source 
tracking and degradation assessments in field studies, finally, we conducted two additional explorative 
tests. On the one hand we examined a limited number of commercial diclofenac products, as an 
indicator of the isotopic variability of diclofenac sources in the environment. On the other hand we 
made a feasibility test to investigate the potential to analyze diclofenac in low concentrations in the 
presence of matrix interferences from actual environmental samples.  
2.3 Materials and Methods 
2.3.1 Chemicals 
A complete list of chemicals used in this study can be found in the supporting material (A3-S1). 
2.3.2 Purification of Commercial Pharmaceutical Products and Treatment for 
Isotope Analysis 
Commercial diclofenac products were directly analyzed via online-derivatization GC-IRMS (see 
below) after dissolving powdered tablets or gels in methanol and subsequently filtering them through 
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PTFE filters (0.2 µM, Carl Roth, Karlsruhe). For EA-IRMS analysis – conducted to obtain reference values 
for comparison with the GC-IRMS results – samples were also purified using column chromatography. 
This procedure was necessary to eliminate any additional carbon and nitrogen sources in the gels or 
tablets which are automatically separated out in the GC-method, but which would interfere in the EA-
IRMS analysis. To this end, powdered tablets and gel products were dissolved in methanol and eluted 
through a glass column (300 x 10 mm, Lenz) filled with silica gel (40-63 µm, Merck, Darmstadt). The 
eluent was pentane:ethylacetate:acetic acid 70:30:1 (v/v/v). Fractions were collected and their purity 
was controlled with thin layer chromatography. All fractions containing diclofenac were mixed and 
evaporated to dryness under N2 and subsequently analyzed on an elemental analyzer (EURO EA, Euro 
Vector Instruments) coupled to a Finnigan MAT 253 isotope ratio mass spectrometer (Thermo Fisher 
Scientific, Bremen, Germany). 
2.3.3 Aerobic Biodegradation Experiment 
Biodegradation of diclofenac was investigated at a concentration of 450 µg L-1 in river water 
exposed to river sediment in three 5 L replicates with one 5 L sterile control. River water and sediment 
were sampled from the Isar river close to Garching (Germany), wet sieved (10 mm) and filled in 5 L glass 
bottles (n= 4). The background concentration of diclofenac in the natural water was below the limit of 
detection (1 ng L-1). The sediment:water ratio was 1:4 (v/v) and bottles were incubated in the dark at 
12 °C on a horizontal shaker (80 rpm) and aerated with filter-sterilized air (~ 100 mL min-1 per bottle). 
The system was equilibrated at 12 °C and the sediment was allowed to settle for one week. Then the 
supernatant was removed and Isar water from the same sampling event was spiked with diclofenac 
(c= 450 µg L-1) and filled into triplicate bottles each containing sediment. A sterile control was prepared 
by autoclaving sediment in a fourth bottle (121 °C, 20 min. 3 bar), adding Isar water containing 
diclofenac (c= 450 µg L-1) and supplemental NaN3 (c= 1 g L
-1). As expected11, the diclofenac concentration 
in this sterile control remained constant over time demonstrating that neither abiotic degradation nor 
sorption processes were relevant for the dissipation of diclofenac (data not shown). No additional sterile 
controls were therefore included. During 86 days 14 samples (1.5 mL) were taken out of each bottle and 
filtered through PTFE filters (0.2 µm) for concentration and transformation product analysis with liquid 
chromatography/tandem mass spectrometry (LC/MS-MS, A3-S2). At selected time points additional 
samples were withdrawn for isotope analysis. Increasing sampling volumes (0.1– 2.3 L) were taken with 
decreasing residual concentrations to obtain sufficient amounts for precise CSIA. These samples were 
enriched and purified using solid phase extraction (SPE). To this end, samples were brought to pH 10.5 
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with NaOH (1M) and passed through Chromabond HRX-A SPE anion exchange cartridges (6 mL, 150 mg, 
Macherey & Nagel, Düren, Germany; for recovery rates see Supporting Information A3-S3). 
Subsequently, cartridges were eluted with methanol (2% formic acid), samples were evaporated, 
redissolved in 500 µL methanol and stored at -20 °C until GC-IRMS analysis. 
2.3.4 Dechlorination Experiment 
To mimic reductive dechlorination, diclofenac was transformed by H2 in the presence of Au/Pd-
nanoparticles which had been coated on microorganisms as described by De Corte et al.28. Briefly, a 
culture of Shewanella oneidensis was grown in Luria Bertani medium and subsequently washed and 
resuspended in M9 medium to an optical density of 1 at 610 nm. Pd(II) and Au(III) were added to 
concentrations of 50 mg L-1 and 1 mg L-1, respectively, and then reduced by exposure to H2 for 48 h. 
Diclofenac was added, resulting in an initial concentration of 20 mg L-1 and the headspace of the serum 
flasks was filled with H2. Samples were withdrawn with a syringe, filtered through a 0.22 µm filter, and 
quantified by HPLC-UV according to De Corte et al.28. 
2.3.5 Online Derivatization GC-IRMS Analysis 
To make the analyte diclofenac amenable to gas chromatographic analysis, the polar carboxyl-
group was converted into a methyl-ester. Online derivatization with trimethylsulfonium hydroxide 
(TMSH, 0.25 M in methanol) was conducted as described previously29, 30. Previous results 29 and data of 
this study (see Supporting Information A3-S4) show that the molar excess of TMSH is a crucial parameter 
for isotope measurements; TMSH was, therefore, added to the samples prior to injection with a molar 
excess of at least 300. Between 1 µL and 100 µL of the analyte/TMSH mixture were injected into a 
temperature programmable injector (Optic 3-SC High Power Injection System, ATAS GL International 
B.V., Veldhoven, Netherlands) equipped with a large volume liner containing glass beads (PAS 
Technology, Magdala, Germany). After evaporation of the solvent, the split flow was set to zero for 5 
minutes and the injector was heated from 40 °C to 300 °C at 10 °C s-1. This flash heating triggered the 
methylation of diclofenac and transferred the formed methyl-diclofenac onto the gas chromatograph 
(TRACE GC Ultra gas chromatograph, Thermo Fisher Scientific, Milan, Italy) equipped with a DB-5 column 
(30 m × 0.25 mm or 0.32 mm, 1 µm film thickness, J&W Scientific, Folsom, Canada). The initial oven 
temperature was 80 °C (1min), ramped to 200 °C with a rate of 17 °C min-1 and then at 6 °C min-1 to 
300 °C (held for 2 min). After chromatographic separation diclofenac was combusted in a Finnigan GC 
combustion interface (Thermo Fisher Scientific, Bremen, Germany) to CO2 and N2 with a NiO tube / CuO-
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
 24 / LII 
NiO reactor operated at 1030 °C (Thermo Fisher Scientific, Bremen, Germany). Isotope values of CO2 and 
N2 were determined with a Finnigan MAT 253 isotope ratio mass spectrometer (Thermo Fisher Scientific, 
Bremen, Germany). Three monitoring gas peaks were measured before and after every run. These 
monitoring gas peaks were used to correct isotope values to the international standards, Vienna PeeDee 
Belemnite for carbon (Eq. 2-1) and air for nitrogen isotopes (Eq.  2-2): 
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2.3.6 Offline Derivatization - Splitless Injection 
An offline derivatization method was established as alternative to the online derivatization 
method to lower the limit of precise isotope analysis as described previously for polar herbicides31. 
Briefly, samples were filtered (0.22 µm) and evaporated in 2 mL amber glass vials to dryness under a 
gentle stream of N2. After adding 400 µL of BF3 (10% in methanol), the vials were incubated for 1 h at 
40 °C. After cooling the remaining reactant was quenched with 400 µL MilliQ water, the methylated 
analytes were extracted three times with 500 µL n-hexane, transferred to a new vial and evaporated 
under a gentle stream of N2 without heating. The aqueous phase was disposed of in a canister of 2 M 
NaOH to quench the toxicity of HF. The dried hexane extract was redissolved in 1500 µL n-hexane and 
between 1 µL and 8 µL were injected splitless at 280 °C into a split/splitless injector (Thermo Fisher 
Scientific, Milan, Italy). After one minute, the split ratio was switched to 1:10. As shown in the 
supporting material (A3-S5) the elevated injection volume did not bias isotope analysis. The injector was 
connected to the same GC-IRMS system and operational conditions, as well as data evaluation were the 
same as described above.  
2.3.7 Offline Derivatization-On-Column Injection 
Since on-column injection is known to be a most sensitive injection technique, a method 
established for atrazine was adapted to diclofenac.32 Briefly, offline-derivatized samples were injected at 
40 °C in a programmable injector (Optic 3-SC High Power Injection System, ATAS GL International B.V., 
Veldhoven, Netherlands) equipped with an on-column liner (A100129; ATAS GL International, 
Eindhoven, the Netherlands) pressed directly onto a fused-silica-methyl-silyl retention gap 
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(3 m×0.53 mm inner diameter, Chromatographie Service GmbH, Langerwehe, Germany). The injector 
temperature was initially at 40 °C (5 min) and then ramped to 280 °C at 2 °C s-1. The column flow was set 
to 0.3 mL min-1 to gentle blow off the solvent inside the retention gap (2 min) and then ramped to 
1.4 mL min-1 within 120 s. The GC was equipped with the same DB-5 column as above, but with a 
modified oven program: 40 °C (4 min) to 200 °C with 17 °C min.-1, then ramped to 270 °C at 6 °C min-1 
(20 min) and finally at 10 °C min.-1 to 290°C (10 min). The operational conditions of the combustion unit 
and the IRMS system were as described above. 
2.3.8 Extraction and Purification from River Water Samples 
To determine the applicability of isotope analysis of diclofenac to field samples 10 L of spiked river 
water were analyzed (c = 1 µgL-1). After filtration (glass fiber No.6, Schleicher & Schüll) the sample was 
split into ten 1 L aliquots and subjected to solid phase extraction (SPE) as described in the 
biodegradation experiment (splitting of the sample was conducted to prevent a potential overloading of 
the SPE cartridge). Unified SPE extracts were evaporated, redissolved in 1 mL MeOH:H2O 1:1 (pH 2) and 
purified by preparative HPLC to minimize matrix interferences (for details see A3-S6). After offline 
derivatization, C- and N-isotope ratios were analyzed by on-column injection GC-IRMS as described 
above. 
2.3.9 Post-Measurement Correction of Carbon Isotope Ratios 
A crucial factor for isotope analysis is the performance of the combustion reactor in the GC-IRMS 
system since previous work has shown that those reactors may produce drifts in isotope values during a 
long sequence of samples 33. A diclofenac lab standard was therefore frequently measured and, when 
necessary, used to correct sample values for such drift as described previously.33, 34 In addition, the 
methylation of diclofenac introduces an extra carbon atom into the molecule changing its bulk carbon 
isotope ratio. To correct for this shift of 13C, standards and samples were derivatized with the same 
batch of TMSH or methanolic BF3, respectively, and isotope values of diclofenac were subsequently 
corrected using Eq. 2-3 and Eq. 2-4. Specifically, Eq. 2-3 was used to calculate the isotope ratio of the 
introduced methyl group (13C(Me)). We note that 13C(Me) needs not be true in absolute terms, but is a 
necessary parameter for the following correction of diclofenac raw data (see below), which adheres to 
the identical treatment of sample and standard. (i) The isotope ratio of the lab standard was determined 
on EA-IRMS (14 C-atoms) to obtain the isotope ratio of the diclofenac moiety (Diclofenac EA). (ii) This 
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value was subtracted from the GC-IRMS measurement of the methylated diclofenac standard (Me-
Diclofenac GC, 15 C-atoms). 
                                       
                 (2-3) 
(iii) Subsequently, isotope values of samples, 13C(Diclofenac Sample) were corrected using the 
13C(Me) 
value of the standard measurements that bracketed their analysis. As can be deduced from Gaussian 
error propagation31 the uncertainty of 13C(Me) in Eq. 2-3 is reduced by a factor of 14 in Eq. 2-4. 
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2.3.10 Evaluation of Isotope Fractionation 
Bulk enrichment factors (ε) were calculated using the linearized Rayleigh equation (Eq. 2-5), which 
links isotope ratios at the beginning (13C0) and after time t (
13Ct) to the remaining substrate fraction f = 
(Ct/C0). 
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(2-5) 
From ε a position-specific apparent kinetic isotope effect (AKIE) can be estimated for diclofenac 
degradation according to  
     ≈           (2-6) 
 (Eq. 21 in Elsner et al.) 35. Because there is only one nitrogen atom, but there are 14 carbon atoms 
in diclofenac, the expressions are 
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2.3.11 Evaluation of Degradation Kinetics 
For the degradation experiments dissipation rates were determined with a pseudo first-order 
kinetic approach. To this end the logarithm was taken of the fraction f = (Ct/C0) of remaining diclofenac 
and plotted against time. The resulting slope of the linear regression curve represents a pseudo-first 
order dissipation constant (kdis) which was used to calculate a dissipation time (dt50; Eq. 2-9). The 
standard error of kdis was used to estimate the uncertainty of the dt50. 
      
     
    
 (2-9) 
2.4 Results & Discussion 
2.4.1 Method Validation & Quantification Limit 
Seven diclofenac products were purified on a silica column, analysed on EA-IRMS (1σ = 0.1‰21) 
and compared to parallel online-derivatization GC-IRMS measurements. Good agreement between both 
approaches was observed for both elements (Tab. 2-1, Fig. 2-1a, 2-1b). At the cost of slightly lower 
precision (see below), the online-derivatization GC-IRMS method is much faster and can facilitate high 
throughput analysis of commercial drugs compared to EA-IRMS. It saves resources because no offline-
preparation is required except dissolving and filtering. Furthermore, GC-IRMS has a higher 
chromatographic resolution than the packed silica column used for preparation prior to EA-IRMS 
analysis. The greatest advantage of GC-IRMS, however, is its excellent sensitivity. A single EA-IRMS 
analysis needs 800 µg diclofenac to analyze 13C and 15N simultaneously. In contrast only 60 ng (33 ng 
C, 1σ = 0.4‰) are needed per injection for GC-IRMS and 3.8 µg (180 ng N, 1σ = 0.5‰) for nitrogen using 
online-derivatization. For even better sensitivity in the analysis of environmental samples the GC-IRMS 
quantification limits can be further lowered by two strategies.  
(a) Online derivatization with TMSH using large volume injection. With the use of large volume 
injection in combination with online derivatization the solvent is evaporated in the injector prior to 
heating of the inlet. For isotope analysis of benzotriazole it was shown that this makes injection volumes 
of up to 100 µL possible.36 While this approach is fairly easy to adapt by prolongation of the vent-phase 
prior to the heating of the injector, it consumes a large volume of precious sample that would be 
needed for replicate analysis or analysis of a second element.  
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 (b) Offline derivatization and subsequent injection into a hot splitless injector. A more efficient 
strategy is the combination of offline-methylation with splitless injection to maximize derivatization 
yield and peak sharpness in comparison to online derivatization. With this technique reliable isotope 
measurements have been tested, and found to be possible down to 10 ng (6 ng C, 1σ = 0.4‰) for carbon 
and 600 ng (30 ng N, 1σ = 0.4‰) for nitrogen (see amount-dependency plots in the Supporting 
Information A3-S7 as well as the finding that injecting up to 8 µL splitless does not bias isotope ratios, 
Supporting Information A3-S5). The quantification limit can be further lowered by offline derivatization 
and subsequent on-column injection as previously shown for atrazine.32 This technique increases the 
quantification limit by a factor of three (3 ng C, 10 ng N) in comparison to splitless injection. These 
amounts correspond to 70 ng and 4 µg diclofenac that are needed in total for one sample that is 
subjected to carbon and nitrogen isotope analysis, respectively (final sample volume 40 µL, injection 
volume 2 µL).  
Table 2-1: Isotope values of direct online-derivatization GC-IRMS analysis & silica-column purified EA-
IRMS measurements; errors are given as precision of replicate measurements (n = 3-6); the total 
uncertainty (2σ) of the GC IRMS and EA IRMS method is 0.8‰ and 0.2‰, respectively; NA= not 
analyzed. 
Letter Producer Product 
13C 
GC-IRMS 
(‰) 
13C 
EA-IRMS 
(‰) 
15N 
GC-IRMS 
(‰) 
15N 
EA-IRMS 
(‰) 
A Hexal Diclac Dispers (2004) -27.1 ± 0.1 -27.2 ± 0.1 -0.7 ± 0.4 -0.7 ± 0.1 
B Hexal Diclac Dispers (2012) -30.0 ± 0.3 -30.5 ± 0.1 -3.2 ± 0.3 -3.3 ± 0.1 
C Dolorgiet Dolgit-Diclo -30.3 ± 0.2 -30.2 ± 0.1 -2.2 ± 0.2 -2.6 ± 0.1 
D Betapharm Diclo dispers -30.3 ± 0.3 -31.0 ± 0.1 -2.3 ± 0.3 -2.0 ± 0.1 
E Novartis Voltaren Retard -30.6 ± 0.3 -30.9 ± 0.1 -2.6 ± 0.7 -3.2 ± 0.2 
F Novartis Voltaren Dispers -31.0 ± 0.2 NA -2.8 ± 0.5 NA 
G Novartis Voltaren Emulgel -29.3 ± 0.5 -29.3 ± 0.1 0.0 ± 0.1 -0.3 ± 0.1 
H ratiopharm Diclofenac-ratiopharm Gel -28.4 ± 0.3 NA -0.6 ± 0.5 NA 
S Sigma Aldrich Lab standard -26.4 ± 0.3 -26.4 ± 0.1 -1.1 ± 0.2 -1.1 ± 0.1 
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In conclusion, the two derivatization methods complement each other nicely. If the focus is on 
fast and safe analysis where no HF is formed during preparation (e.g. for product analysis in laboratory 
studies) online-methylation is preferable. In contrast, if a low quantification limit for isotope analysis is 
essential, as is the case for environmental samples, offline derivatization with on-column injection 
delivers excellent sensitivity. Because the degradation experiments of this study were conducted in the 
lab without the need for extra sensitivity they were analyzed using the online-derivatization method. 
2.4.2 Source Variability and Potential for Source Tracking 
Knowledge about isotope ratios of diclofenac products is important to be aware of the variability 
of diclofenac sources the environment, such as sewage treatment plants. Moreover, it was shown that 
especially N-isotope analysis of micropollutants has the potential for source appointment in the 
environment. 36 Specifically, for pharmaceutical products such as aspirin, ibuprofen or naproxen, it has 
been shown that the analysis of stable isotope ratios can be used as a fingerprint for product 
authentication and to track sources.37-39 In one case it was even possible to determine the location of an 
illegal production site by evidence from isotope analysis.40  
Given that our method allows isotope analysis of diclofenac in complex matrices, at low 
concentrations (BF3 method) and without laborious sample preparation (TMSH method), we conducted 
an explorative survey to investigate the typical variability of diclofenac source isotope ratios. To this end, 
two or three aliquots of nine products were analyzed twice by online-derivatization GC-IRMS. The 
results are shown in Table 2-1 and Figure 2-1c as a dual-element isotope plot. Different tablets or gel-
aliquots from the same product did not show a higher deviation than replicate analysis of one aliquot, 
reflecting a homogeneous isotope distribution within the products. Consequently all aliquot-
measurements were summarized and treated as one sample. The total range of isotope ratios was 5‰ 
and 4‰ for carbon and nitrogen, respectively.  
This relatively low source variability is similar to the study of Jasper et al.41 who analyzed a larger 
data set of 53 topiramate (C12H21NO8S) products with EA-IRMS and found a range of 8‰ for both carbon 
and nitrogen. In terms of source appointment Figure 2-1c shows that the analysis of two elements 
clearly enhances resolution and most of the products can be distinguished in a dual isotope-plot. Isotope 
values of some products were quite close, e.g. of product E and F from the same producer or of E, C and 
D from different producers. This may be explained by the fact that diclofenac is often synthesized by the 
same pathway and raw materials so their isotope values may coincide. The same applies if two 
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companies share the same supplier. In contrast, in other cases differences were greater, and in one case 
a clear shift of carbon and nitrogen isotope ratios was detected for exactly the same product (A+B) of 
the same company sold in different years. The date of expiry differed by eight years for both batches 
and therefore likely reflects a change in either production pathway or materials used in synthesis. An 
isotope shift due to aging is unlikely because peak amplitudes in analysis of equal amounts from both 
batches were similar. If isotope fractionation had been caused by degradation this would have been 
reflected in smaller peaks.  
 
Figure 2-1. Comparison of six products and the lab standard (S) analyzed by EA-IRMS and GC-IRMS for 
carbon (a) and nitrogen analysis (b). In total eight products (A-H) and the reference standard (S) were 
measured by GC-IRMS (c) and shown as a dual isotope plot. Given are mean vales (n= 3-6) and 
confidence intervals (0.95) for carbon and nitrogen isotopes and the dotted line represents the uncertainty 
of the slope as ± 2σ. 
In conclusion, although not possible in all cases, a distinction based on isotope values was accomplished 
for the majority of the pharmaceutical products. Our finding therefore shows the potential for 
producers to track batches and even to verify their products if raw materials for production are chosen 
carefully and isotope ratios of manufactured products are recorded. From an environmental perspective 
the relatively narrow isotope range has two consequences. On the one hand it limits the application of 
CSIA for source appointment. The reason is that except for hospital effluents, usually several producers 
are mixed and the uncertainty of field sample analysis is often higher than for relatively clean and highly 
concentrated pharmaceutical products. On the other hand this low variability is beneficial for an easier 
characterisation of the initial isotope ratio in degradation studies with a variable input, such as the 
outflow of a sewage treatment plant. 
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2.4.3 Isotope Fractionation During Degradation by Aerobic River Sediment  
Kinetics. A proof-of-principle biodegradation experiment was conducted to investigate isotope 
fractionation under environmentally relevant conditions. To this end diclofenac was incubated in an 
aerobic sediment-water-system containing an indigenous microbial community from a river. During the 
experiment the diclofenac concentration in the water phase decreased by 71% within 86 days. The 
dissipation of diclofenac from the water phase could be described with a pseudo-first order rate 
resulting in a dissipation rate constant of kdis= -0.015 (± 0.002) and an average dissipation time (50%; 
dt50) of 47 d (± 4 d) (see evaluation in the Supporting Information A3-S8). The diclofenac concentration 
in the sterile control remained stable at the initial level. Thus, sorption to the sediment or abiotic 
degradation was not a significant sink in the chosen setup and dissipation can be attributed to 
degradation. Compared to previous studies the average dissipation time dt50 of 47 d falls between that 
of a flume experiment with river sediment (dt50 3 – 9 d)
3 and bioreactors with sewage sludge, where 
diclofenac was not eliminated within 30 d42 or only to a minor extent (20% degradation after 122 d).30  
Product formation. During diclofenac degradation a hydroxylated transformation product (TP) 
was detected by LC-MS/MS analysis that could be identified as 4’-OH-diclofenac by comparison to an 
authentic standard (Fig. 2-3 and supporting material A3-S8). This TP has previously been found in 
sewage treatment plants12, 14 and in river-water-test-systems.11, 15 4’-OH-diclofenac was not present at 
t=0 and appeared at low, but steadily increasing concentrations of up to 14 µg L-1 (A3-S8). Assuming no 
further degradation this amount would correspond to 3% of the transformed diclofenac; the true value 
may be somewhat higher, because hydroxylated diclofenac has been shown to be further 
biodegradable.11, 15 
Isotope fractionation and possible mechanisms. No significant carbon isotope fractionation was 
observed during aerobic biodegradation (Fig. 2-2a). In contrast, nitrogen isotopes shifted from -0.2‰ to 
9.4‰ corresponding to a normal isotope effect of εNitrogen = -7.1‰ (AKIEnitrogen of 1.007)(Fig. 2-2b). The 
same qualitative trend (εN = -10‰) was previously observed for oxidation of diphenylamine by MnO2.
43 
Two mechanistic scenarios can explain the occurrence of N-isotope fractionation (Fig. 2-3). (1) Enzymatic 
monohydroxylation of alkylated anilines would be in agreement with the detection of 4’-hydroxy 
diclofenac, which is also formed by diclofenac transformation via human CYP450 enzymes.44 While the 
initial SET (single electron transfer) step  Ia  would be expected to cause an inverse N- isotope effect, 
step IIa may cause a normal N-isotope effect (Fig. 2-3).45 This hypothesis is based on calculations for 
diphenylamine, which can be regarded as the molecular backbone of diclofenac, where C-N-bonds were 
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shown to be stiffer in the radical-cation than in diphenylamine.43 Taking steps Ia and IIa together, an 
observable normal N-isotope effect would result if the oxidation step (IIa) was rate limiting. (2) An 
alternative mechanistic hypothesis could be biotic diclofenac transformation via dioxygenation, which 
may also lead to a normal N-isotope effect (Fig. 3). While the N-atom is not involved in the initial 
reaction step (Ib), a C-N bond is broken in the second step (IIb). If this bond cleavage is rate limiting, it 
could explain the observed isotope fractionation. Indeed, dihydroxylation has already been investigated 
for diphenylamine46 and normal N-isotope fractionation (εN = -1.0‰) was measured..
43 
 
Figure 2-2. Isotope fractionation of carbon (a) and nitrogen (b) during aerobic biodegradation (three 
replicates). Isotope values are given as mean values with 95% confidence intervals. The slope of the 
regression line is equivalent to the enrichment factor ε and the dotted line represents the initial isotope 
value of diclofenac (t = 0) ± 2σ. The diclofenac used in this experiment had a different isotopic 
composition than in the dechlorination experiment. 
Samples were therefore screened with LC-MS/MS for potential cleavage products, such as 
2,6-dichloronaniline, 2,6-dichlorophenol and dihydroxyphenyl acetic acid, but no additional TP could be 
detected. Their absence may be explained by further transformation, the relatively high detection limit 
for 2,6-dichloronaniline (50 µg L-1), or irreversible binding to humic substances as shown for 
3,4-dichloroaniline.47 Because the exclusive detection of hydroxylated products (including corresponding 
quinone structures) agrees with previous studies using natural sediment11,15 or plants48, in depth TP 
analysis was not further pursued. 
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Figure 2-3. Possible reaction pathways for diclofenac: while the Monooxygenase pathway forms 
4’-hydroxy diclofenac via initial single electron transfer, concerted dioxygenation (Dioxygenase-pathway) 
leads to 2,6-dichloroaniline and 2,3-dihydroxyphenyl acetic acid.
46
 
2.4.4 Reductive dechlorination 
Isotope fractionation was further investigated in a model system for reductive dehalogenation, 
which is an important type of environmental transformation.49-51 In addition, this system served as an 
indicator if carbon isotope fractionation can be detected at all in diclofenac. Since GC-IRMS analyzes the 
average δ13C value of all 15 C-atoms in methylated diclofenac, any potential enrichment at the reactive 
position is diluted by a factor of 15, so previous studies suggested that the threshold for detectable 
carbon isotope fractionation would be between 11 and 14 C-atoms.52 Diclofenac was dechlorinated 
under anoxic conditions in the presence of hydrogen by Pd/Au-coated microorganisms 28. This is an 
abiotic reaction which takes place at the outer cell wall, where microorganisms are only used as a carrier 
for the catalyst. After H2 dissociates at the catalyst surface, diclofenac is also sorbed and sequentially 
dechlorinated.28 Diclofenac was thereby degraded with a dt50 of 1.35 h (k = 0.515 h
-1). During 
degradation carbon isotope values shifted from -32.1‰ to -20.1‰ corresponding to an εC of -2.0‰ (Fig. 
4a). The magnitude of carbon fractionation (AKIEcarbon= 1.029) agrees well with previous work where an 
AKIEcarbon values of around 1.03 were observed for the reductive dechlorination of tetrachloromethane 
by several Fe(II) bearing minerals (Streitwieser Limit 1.057).53, 54 In contrast to carbon isotope 
fractionation, no nitrogen isotope fractionation was detected (Fig. 4b). This is in agreement with the 
reductive dechlorination mechanism, where a C-N bond is not directly involved.  
The results from this model system therefore show that carbon isotope fractionation could indeed 
be detected in diclofenac and serve as indicator for strongly fractionating degradation processes such as 
reductive transformation. Reductive dechlorination was shown to be the first step of diclofenac 
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photodegradation13, 55 and is an important pathway for biodegradation of many chlorinated 
contaminants.49-51 Such a shift in carbon isotope values could therefore indicate diclofenac 
dechlorination in field samples. In addition, the use of metal-catalysts to dechlorinate contaminants is 
discussed as a removal strategy for micropollutants in treated waste water and this process could be 
monitored by CSIA.28 
 
Figure 2-4. Isotope fractionation of carbon (a) and nitrogen (b) during the dechlorination experiment 
conducted with three replicates. Carbon isotope values are given as mean values with confidence 
intervals (95%). Due to the high quantification limit of nitrogen isotope analysis using online derivatization, 
samples could only be measured once and until 60% degradation; error bars represent the total error of 
the δ15N measurement (2σ = 0.8‰). The slope of the regression line is equivalent to the enrichment 
factor ε and the dotted line represents the value at t = 0 ± 2σ. The diclofenac used in this experiment had 
a different isotopic composition than in the biodegradation experiment. 
2.4.5 Environmental Significance 
This study is the first to explore the potential of CSIA to assess degradation of pharmaceuticals 
using diclofenac as a model compound. We have found that aerobic degradation by oxic river sediment 
was accompanied by strong nitrogen isotope fractionation, whereas reductive dechlorination showed 
significant carbon, but no nitrogen isotope fractionation. Consequently, the two transformation 
pathways may be distinguished by dual element isotope analysis. Because CSIA neither depends on 
transformation product analysis nor on concentration measurements, this approach delineates a new, 
complementary line of evidence to evaluate environmental degradation of diclofenac. 
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To put this observed magnitude of degradation-associated isotope fractionation into perspective, 
we also conducted a complementary survey of commercial diclofenac products. Their isotope values 
spanned a range of 5‰ and 4‰ for carbon and nitrogen, respectively. This indicates that source isotope 
ratios – e.g. the outflow of a sewage treatment plant – need to be well constrained in order to 
unequivocally detect the “on-top” changes by isotope fractionation that are caused by degradation. In 
the case of very pronounced isotope fractionation, however – such as for nitrogen fractionation during 
microbial oxidation – values may so clearly exceed the source range of 4‰ that they could allow to 
identify degradation even without definite knowledge of source ratios (e.g. 10‰ shift of δ15N after 70% 
degradation).  
Finally to explore the CSIA approach not only with respect to process-associated isotope 
fractionation (“Do we see changes in isotope values?”), but also with respect to its applicability (“Can we 
actually measure isotope ratios under real world conditions?”) we extended our study to test the 
feasibility of diclofenac CSIA at low concentrations and with a complex matrix. A spiked river water 
sample (1 µgL-1) was extracted by SPE, purified by preparative HPLC (S6)32, and successfully analyzed 
after offline derivatization by on-column injection GC-IRMS. Isotope ratios were in perfect agreement 
with EA-IRMS data: the δ13C value in river water (-26.4 ± 0.5‰) coincided with the EA-IRMS value 
of -26.4‰, whereas the δ15N value in river water (-1.2 ± 0.4‰) was within error of the EA-IRMS value 
of -1.1‰ (S9). Based on this first test, the sensitivity of nitrogen isotope measurements was already in 
the range of sewage treatment plants outflow4, 55 and in the case of carbon, it was even better. The high 
δ13C peak of the sample (2500 mV, A3-S9) indicates that a peak ten times lower (250 mV), corresponding 
to a concentration of 100 ng L-1, could be analyzed as well, which is in the range of typical diclofenac 
concentrations in surface waters.3, 4, 55, 56 These limits for C- and N-isotope analysis are among the lowest 
reported for non-volatile compounds21, 32 and we demonstrated that the individual techniques are 
suitable for isotope analysis of diclofenac. Future studies may therefore use this study as a basis to even 
further optimize individual steps, such as increasing the recovery rate of the SPE or by extracting larger 
sample volumes.  
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3.1 Abstract 
Diclofenac is one of the most frequently detected pharmaceuticals in natural waters, but its 
environmental transformation reactions remain imperfectly understood. Compound specific isotope 
analysis (CSIA) has been brought forward to as a new line of evidence based on isotope effect 
measurements. 15N/14N ratios changed during biotransformation (εN= -7.1‰) whereas 
13C/12C ratios 
changed during dechlorination. This study targets further important transformation reactions in 
environmental and engineered systems. Photolysis caused inverse N-isotope fractionation (εN= +1.9‰) 
and can therefore be distinguished by CSIA from biotransformation. Also transformation of diclofenac by 
ozone was accompanied by inverse N-isotope fractionation (εN= +1.5‰); here, the magnitude of 
fractionation could even indicate the site of O3 attack in diclofenac. Further insight into underlying 
oxidation mechanisms was obtained from reactions of diclofenac with ABTS radicals – a well-established 
outer sphere single electron transfer (SET) oxidant – and with MnO2 – an oxidant with unknown 
mechanism.. While inverse nitrogen isotope fractionation (εN= +3.8‰) with ABTS radicals confirmed the 
SET mechanism, normal isotope fractionation with MnO2 (εN= -7.3‰) indicated that a different reaction 
chemistry was at work. The similarity of nitrogen isotope effects in biodegradation and with MnO2 may 
indicate a possible common pathway for which first evidence is given by CSIA.  
 
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
 42 / LII 
3.2 Introduction 
Pharmaceuticals are used world-wide in large amounts and end up in wastewater treatment plants 
due to incomplete metabolization in the human body.1, 2 The failure to remove diclofenac in wastewater 
treatment plants leads to a continuous emission and a steady-state exposure in rivers, surface and even 
ground water.3-5 Consequently, the self-cleaning potential of aquatic ecosystems is of great interest. 
Even though transformation processes can be simulated in the laboratory systems including the 
identification of transformation products (TPs) via (high resolution) mass spectrometry and NMR, the 
natural transformation of many pharmaceuticals remains is not fully understood for the following 
reasons.6-10 (i) In contrast to laboratory experiments, transformation in natural systems is difficult to 
quantify due to incomplete mass balances; (ii) transformation mechanisms are typically elusive; (iii) 
detectable TPs often account only for a fraction of the mass balance and the same TP can be formed by 
different reaction pathways (Fig. 3-1).  
A prominent example is the anti-inflammatory diclofenac, one of the most widely used 
pharmaceuticals11 and most frequently detected ones in the environment.3, 12 In laboratory studies 
diclofenac is efficiently transformed by (sun-) light within hours.13-16 However, it takes days to observe 
pronounced transformation in water/sediment batch studies.13, 17, 18 In the case of limited sunlight 
availability,, phototransformation may not be the dominant way of diclofenac transformation, 14, 15 while 
biotransformation rates can more than double if the exchange between the water body and the 
hyporheic zone is increased.19 Unfortunately, the processes that govern diclofenac transformation in the 
environment are still not elucidated. While TPs provide a direct evidence for transformation, their 
detection is challenging due to further transformation,9, 20, 21 adsorption to humic substances22, 23 and by 
lack of adequate analytical methodologies. Moreover, the lack of commercial standards often impedes a 
quantitative determination of TPs.24 For example, several studies have reported the detection of 
hydroxylated diclofenac in laboratory experiments (Fig. 3-1 (6, 7)).9, 10, 17, 20 Among these studies, only 
one has provided quantitative data for hydroxylated diclofenac, showing that it only accounts for a few 
percent of diclofenac transformation.17 Therefore, there is need for a supplementary technique which 
does not rely on the identification and the determination of TPs, but which can nonetheless provide 
information on transformation processes in the environment. 
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Fig.3-1. Transformation pathways of diclofenac during single electron oxidation (SET) by ABTS (2-4), 
photolysis
13, 25
 (4,5), ozonation
26, 27
 (7-10) oxidation by MnO2-
28
 and biotransformation
9, 17
 (6-8); TP 4-8 
were also detected in this study  
Very recently compound specific isotope analysis (CSIA) has been brought forward to provide such an 
independent line of evidence for the transformation of diclofenac.17 This technique analyzes the stable 
isotope ratios of C and N of diclofenac at natural abundance (13C/12C, 15N/14N) and detects 
transformation reactions by a shift in isotope ratios during transformation.29-31 For example, 
biotransformation of diclofenac by river sediment was found to be by 7.1‰ slower with 15N- than with 
14N-containing molecules (εN = -7.1‰) leading to progressively higher 
15N/14N ratios in the remaining 
diclofenac during transformation.17 Because this line of evidence relies on different isotopologue-
specific rates in the parent rather than the daughter compound, transformation can be studied by CSIA 
of diclofenac without the explicit need to detect potential TPs.32 In a second experiment targeting 
reductive dehalogenation of diclofenac, a similar trend was observed for 13C/12C ratios in diclofenac 
(εC = -2.0‰), whereas no changes in 
15N/14N were found. These results demonstrate that CSIA delivers 
information on two levels. On a descriptive level, C and N isotope analysis of diclofenac can be used to 
simply detect oxidative and reductive transformation.17 On a mechanistic level, isotope fractionation 
also allows exploring underlying transformation mechanisms, since – ultimately – isotope effects are 
caused by differences in transition states.32, 33 While our recent study, therefore, highlighted the 
potential of CSIA, it also brought up new questions. On the one hand, there is the pragmatic interest if 
CSIA can track other environmentally relevant transformation pathways such as photolysis. On the other 
hand, there is a mechanistic interest in the observed aerobic biotransformation. How does its 
mechanism compare with oxidation reactions in other environmental and engineered systems? Is N-
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isotope fractionation during biotransformation related to the formation of hydroxylated diclofenac or 
does it indicate an additional transformation pathway that was so far overlooked in TP analysis? 
The present study explored whether CSIA can track and even distinguish environmentally relevant 
transformation processes of diclofenac. To this end four additional processes were investigated. 
Photolysis was studied, because it may be an important elimination process in surface waters and in 
(waste-) water treatment. Isotope fractionation during ozonation was investigated, since it is a key 
technique to eliminate diclofenac in wastewater treatment plants and waterworks. Further oxidations of 
diclofenac were studied with MnO2 as an environmentally relevant mineral phase and with 
electrochemically oxidized ABTS as an oxidative outer sphere single-electron transfer reagent.28, 34 
3.3 MATERIALS AND METHODS 
3.3.1 Chemicals 
A complete list of chemicals used in this study can be found in the supporting information (A4-S1). 
3.3.2 Phototransformation 
Quartz glass tubes (39 cm long, 4.5 cm in diameter) were filled with 700 mL Millipore water or river 
water (sampled from Isar river, Germany) spiked with diclofenac (C0 = 100 mg L
-1) and were exposed to 
sunlight from 9 a.m. to 8 p.m. on a sunny summer day (latitude 48.22° N). Samples were taken at 
different time points and separated for concentration and isotope analysis. For concentration and TP 
analysis (using LC-MS/MS) 100 µL sample aliquots were mixed with 800 µL Millipore water and 100 µL 
internal standard (13C6-diclofenac, c = 25 mg L
-1, in methanol) and filtered with a PTFE filter (0.22 µm). 
For GC-IRMS analysis larger sample volumes were taken (10-60 mL) and extracted three times with 
dichloromethane after addition of HCl (Ctotal ~ 0.05 M). The dichloromethane extract was evaporated to 
dryness and samples were methylated by BF3/methanol as described previously.
17 
3.3.3 Ozonation 
Groundwater (DOC ~ 1.5 mg L-1) was spiked with diclofenac (C0 = 30 mg L
-1) and different amounts of 
ozone to obtain O3-diclofenac ratios between 1:7.5 and 10:1. Aqueous stock solution of ozone (approx. 
1 mM) was prepared by sparging ozone-containing oxygen through deionized water cooled in an ice-
bath. Ozone was generated from an O3-geneator (Ozon generator 300, Fischer Technology, Germany). 
To exclude the influence of OH-radicals, duplicate experiments were also performed in the presence of 
tert-butanol (100 mM) as radical scavenger. Samples were prepared as described above for the 
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phototransformation experiment, except that those for GC-IRMS analysis (240 mL) were freeze-dried 
prior to liquid-liquid extraction.  
3.3.4 Oxidation by MnO2 
An MnO2 stock solution was synthesized according to Murray et al.
35 and oxidation of diclofenac by 
MnO2 was accomplished in analogy to Forrez et al.
36. Briefly, 900 mL Millipore water were mixed with 
8 mL of NaOH (1 M) and 40 mL of NaMnO4 (0.1 M) under constant sparging with N2. 60 mL of MnCl2 
(0.1 M) were added dropwise under continuous stirring. MnO2 particles were allowed to settle and the 
supernatant was replaced by de-ionized water until the electric conductivity of the solution was below 
3 µS cm-1. This stock solution (final volume 1 L) was stored at 7 °C and used within one week. Diclofenac 
oxidation was initiated by adding 100 mL of MnO2 stock solution to 900 mL diclofenac solution 
(50 mg L-1, pH 6.2, 10 mM NaH2PO4 / Na2HPO4) under continuous stirring. Samples for concentration and 
isotope analysis (10-60 mL) were prepared as described for the phototransformation experiment, with 
the exception that MnO2 particles were dissolved by addition of 20% ascorbic acid (v/v, 20 mM, pH 11) 
prior to filtration or extraction.  
3.3.5 Single electron transfer by ABTS 
Oxidation of diclofenac by ABTS was performed in an anoxic glovebox using anoxic stock and buffer 
solutions as described previously.37 ABTS●- was generated by direct electrochemical oxidation of ABTS2- 
(0.5 mM, pH 6.2, 0.1 M KH2PO4, 0.1 M NaCl) at a potential of 0.79 V (SHE) in an electrolysis cell described 
by Aeschbacher et al.38. The working current was monitored until a stable background value was 
reached. Variable amounts of ABTS●- (0-245 μM) were immediately added to amber glass vials 
containing buffered diclofenac solution (30 mg L-1, pH 6.2, 0.1 M KH2PO4, 0.1 M NaCl) resulting in 
different degrees of diclofenac oxidation in each of the 30 mL samples. Samples for concentration and 
isotope analysis (30 mL) were taken and prepared as described for the phototransformation experiment, 
except that no HCl was added during DCM extraction. This HCl addition had no influence on the 
complete extraction of diclofenac from the aqueous phase (recovery rate ~100%). 
3.3.6 Detection methods 
Concentrations of diclofenac, 4’OH-diclofenac, and phototransformation products were determined 
by LC-MS/MS (Agilent 1200 binary pump coupled to an ABSciex API 2000 Q-TRAP mass spectrometer, 
see also Supporting Information A4-S2). Samples from experiments with O3, ABTS and MnO2 were 
monitored for TPs using a Hybrid Linear Ion Trap-Orbitrap Mass Spectrometer (LTQ Orbitrap Velos, 
Thermo Scientific, Bremen, Germany) coupled to a liquid chromatography system (Accela pump and 
 COMPOUND SPECIFIC ISOTOPE ANALYSIS TO TRACK SOURCES AND INVESTIGATE TRANSFORMATION OF MICROPOLLUTANTS 
 46 / LII 
autosampler from Thermo Scientific). Full scan experiments were performed in positive electrospray 
ionization (ESI) and atmospheric pressure chemical ionization (APCI) mode using a mass range of 60-600 
m/z. Data-dependent acquisition was used to obtain further information of the fragment ions. For this, 
full-scan experiments were followed by MS2 and MS3 scans for the two most intense ions. An external 
calibration was performed prior to the analysis of each batch to ensure accurate mass determinations 
-butylamine, caffeine, and Ultramark 1621 
(mixture of fluorinated phosphazines) was used for mass calibration.  The mass accuracy was always 
within 0.5 ppm.39 
Isotope ratios of diclofenac were analyzed by GC-IRMS as described previously.17 Briefly, methylated 
samples (in hexane) were either injected with a split ratio of 1:10 or splitless into a split/splitless injector 
(Thermo Fisher Scientific, Milan, Italy) at 280 °C with a flow rate of 1.4 mL min-1. Separation was 
achieved by a gas chromatograph (TRACE GC Ultra gas chromatograph, Thermo Fisher Scientific, Milan, 
Italy) equipped with a DB-5 column (30 m × 0.25 mm, 1 µm film thickness, J&W Scientific, Folsom, 
Canada). The GC temperature was ramped from 80 °C (1 min) to 200 °C with a rate of 17 °C min-1 and 
then at 6 °C min-1 to 300 °C (held for 2 min). After chromatographic separation diclofenac was 
combusted in a Finnigan GC combustion interface (Thermo Fisher Scientific, Bremen, Germany) to CO2 
and N2 with a NiO tube / CuO-NiO reactor operated at 1000 °C (Thermo Fisher Scientific, Bremen, 
Germany). Isotope values of CO2 and N2 were determined with a Finnigan MAT 253 isotope ratio mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany). For quality control, a diclofenac lab 
standard with known isotopic signature was analyzed in the same way as the samples at least every 
ninth injection. All reported isotope values were corrected to international reference materials, Vienna 
PeeDee Belemnite for carbon (Eq. 3-1) and air for nitrogen isotopes (Eq. 3-2).40 δ13C values were 
additionally corrected for the introduced methyl-group.17 
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3.3.7 Isotope analysis to evaluate (competing) transformation mechanisms 
Isotope ratios of a micropollutant (Rt, R0) are directly correlated to the extent of transformation (Ct/C0) 
by the enrichment factor ε (Eq. 3-3).32 If two processes compete with each other, e.g. biotransformation 
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and phototransformation, the overall isotope enrichment (εtotal) depends on the first-order kinetic 
constants (kPhoto, kBio) and the enrichment factor (εPhoto, εBio) of both transformation pathways (Eq. 3-4).
41 
In return, the share of one pathway (e.g. FBio) can be calculated if εtotal is determined and εBio and εPhoto 
are known from separate experiments (Eq. 3-5).42 
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3.4 Results & Discussion 
3.4.1 Phototransformation 
Phototransformation can rapidly eliminate diclofenac. We tested if its relevance can directly be 
assessed by CSIA and if it can be distinguished from biotransformation. C and N isotope ratios of 
diclofenac were analyzed during sunlight-induced photolysis in ultrapure and river water. The half-life 
time of diclofenac was 2.4 ± 0.03 h in Isar river water and 2.8 ± 0.1 h in ultrapure water, which is 
consistent with half-lives reported in the literature.13-16 We also detected known photolysis TPs, 
including 8-chlorocarbazole-1-acetic acid, which is formed by HCl elimination (Fig. 3-1. (5), supporting 
information A4-S3).21, 43 
Isotope fractionation during photolysis of diclofenac was consistent for both types of water (ultra 
pure water: εC = +1.1 ± 0.1‰, εN = +2.0 ± 0.1‰; river water εC = +0.7 ± 0.1‰, εN = +1.9 ± 0.1‰). (Fig. 3-
2, Tab. 3-1). An inverse N-isotope effect of diclofenac qualitatively agrees with the direct photolysis of 
atrazine, where an inverse effect was also observed (εN = +4.9‰).
44 As discussed by Hartenbach et al.44 
interpretation of isotope fractionation during photo-excitation is difficult. However, a secondary N-
isotope effect appears plausible, because photo-excitation affects the N-atom as part of the π-system of 
diclofenac. Although further research is needed to investigate the underlying mechanism, Fig. 3-2 shows 
that bio- and phototransformation can be distinguished by isotope analysis of diclofenac. Consequently, 
CSIA can be used to investigate simultaneous bio- and phototransformation of diclofenac in rivers 
independent of boundary conditions and the detection of meta-stable TPs (Fig. 3-1 (5), supporting 
information A4-S3).21 
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Fig. 3-2. Carbon (left) and nitrogen (right) isotope fractionation of diclofenac during photolysis in river 
water (this study, blues circles) and biotransformation in a river water/sediment-system (adopted from 
Maier et al.,
17
 red diamonds) from the same river; the dashed line represents the isotope ratio of 
diclofenac at t0 ± 2σ. 
3.4.2 Ozonation 
An inverse N-isotope fractionation (εN = +1.5 ± 0.2‰) was observed during diclofenac ozonation 
together with the formation of diclofenac-2,5-iminoquinone (Fig. 3-1 (8)) and some hydroxylated TPs 
(Fig. 3-3, Tab. 1, supporting information A4-S4).27, 45, 46 The direction and magnitude of isotope 
fractionation can be rationalized when considering possible reaction mechanisms. Two sites have been 
suggested for the initial attack of ozone in diclofenac. An attack at the N-atom would lead to a cationic 
intermediate (Fig. 3-1 (9)). Alternatively, an attack at the para-position of the non-chlorinated aromatic 
ring would increase the double bond character of the C-N bond as partial imine bond as shown in Fig. 3-
1 (10).37 In both cases, the bond stiffness of N is increased in the transition state which usually leads to 
an inverse isotope effect.26, 27, 47 However, a direct attack at the N-atom would probably cause a primary 
N-isotope effect of greater magnitude. Therefore, a secondary isotope effect caused by attack at the 
distant para position (Fig. 3-1 (10)) appears to be more consistent with the observed, small inverse 
nitrogen isotope fractionation. The second mechanistic scenario is corroborated by the pathway of 
aniline ozonation which has been inferred from detected TPs.27  
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A further possibility involves the reaction with hydroxyl radicals generated from ozone. This reaction 
represent the major breakdown path during ozonation for a number of persistent pollutants.45 However, 
reactions of hydroxyl radical with diclofenac can be excluded for two reasons. (1) A comparison of the 
pseudo-first order constants of reactions with ozone and hydroxyl radical indicates that reaction with 
ozone are expected to be 105 times faster: kOH’ = 7.5 × 10
-3 s-1 versus kO3’ = 10
3 s-1 (supporting 
Information A4-S5). 27,48 (2) In a second experiment hydroxyl radicals were quenched with the radical 
scavenger tert-butanol.26 As shown previously, less O3 was needed to transform diclofenac but isotope 
fractionation showed no significant difference compared to the experiment without the radical 
scavenger (Fig. 3-3). Hence, isotope fractionation is clearly attributable to the reaction of diclofenac with 
ozone. For the first time, we demonstrated that ozonation can be tracked by a small, but significant, 
inverse nitrogen isotope effect. Our findings may not only be important for diclofenac but could give a 
first indication on the isotope fractionation of other contaminants, because many micropollutants 
contain aniline moieties. 
 
Fig. 3-3. Carbon (left) and nitrogen (right) isotope fractionation of diclofenac during ozonation with and 
without the hydroxyl radical scavenger tert-butanol (t-BuOH); the dashed line represents the initial isotope 
ratio of diclofenac ± 2σ. 
3.4.3 Insights into oxidation mechanisms – ABTS & MnO2 
In a recent study17 we investigated aerobic biodegradation of diclofenac in river sediment. Observed 
changes in 15N/14N ratios were opposite to the trends measured during photodegradation or ozonation 
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(Figure 3-1): they showed a strong, normal nitrogen isotope fractionation. Intriguingly, analysis of 
transformation products was unable to elucidate the underlying biotransformation pathway. The 
products that were detected showed a ring hydroxylation distant to the N atom which cannot explain 
the pronounced normal nitrogen isotope effects (Fig. 3-1 (6)).17 Oxidative single electron transfer (SET) is 
frequently proposed as a putative reaction mechanism in aerobic biodegradation.49-51 Therefore, we 
compared isotope fractionation during aerobic biotransformation of diclofenac with two systems for 
which SET was suggested previously. 28, 34 
The reaction of diclofenac with electrochemically generated ABTS radicals was studied as a well-
established outer-sphere SET reagent that has previously been used to investigate SET of amines by N-
isotope analysis.34 During transformation of diclofenac by ABTS no changes in carbon isotope ratios, but 
pronounced inverse N-isotope fractionation was measured (εN = +5.7 ± 0.3‰). These results agree with 
literature data for p-CH3-aniline at pH 7 where also an inverse effect N-isotope effect of εN = +3.8‰ was 
observed with ABTS.52 In addition, we detected TPs indicative of radical coupling which typically 
indicates an initial one electron abstraction (Fig. 3-1 (4), supporting information A4-S6).37  
In reaction with MnO2, SET has also been proposed to occur, but in addition hydroxy-diclofenac and 
its corresponding quinone derivative have been reported, in analogy to the product we observed during 
biotransformation (Fig. 3-1 (7, 8)).17 As observed previously, diclofenac transformation by MnO2 
followed a biphasic kinetics in our experiment accompanied by the formation of hydroxylated diclofenac 
and its corresponding quinone (A4-S4, A4-S7).36 Because 75% of diclofenac was transformed within 
10 min and the solution contained only chemicals in deionised water, a biological transformation can be 
ruled out. Diclofenac oxidation by MnO2 showed small, but significant, C-isotope fractionation (εC = -1.5 
± 0.1‰) and pronounced normal N-isotope fractionation (εN = -7.3 ± 0.3‰). These enrichment factors 
are in good agreement with previously published data for the MnO2 catalyzed oxidation of 
diphenylamine which has the same molecular backbone as diclofenac (εC = -2.3‰, εN = -10.0‰).
52 
However, the normal N-isotope effect during the reaction with MnO2 is in contrast to the inverse 
isotope fractionation during SET with ABTS. At the same time, the MnO2 data fit well with the N-isotope 
enrichment of diclofenac in oxic river sediment (εN  = -7.1‰).
17  
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Fig. 3-4.Carbon (left) and nitrogen (right) isotope fractionation of diclofenac during transformation by 
MnO2 (red circles) and ABTS (blue diamonds); the dashed line represents the isotope ratio of diclofenac 
at t0± 2σ 
These findings confirm that oxidation with ABTS occurs via SET which is supported by the detection of 
coupling TPs in experiments with ABTS. This mechanism is backed up by calculations that predict an 
inverse N-effect for SET.52 Thus, we conclude that oxidation with ABTS is a good model system for outer-
sphere SET, which implies that for biotransformation and oxidation by MnO2 of diclofenac and 
diphenylamine an outer-sphere SET mechanism can be excluded.52 Moreover, it appears unlikely that 
the formation of small amounts of mono-hydroxylated diclofenac (see supporting information A4-S7) 
caused the pronounced N-isotope fractionation of εN = -7‰ during biotic- and MnO2 transformation of 
diclofenac. This is supported by recent results for benzotriazole which showed that even if an aromatic 
amine is exclusively transformed via hydroxylation the maximum enrichment is εN = -3‰.
53 Hence, we 
conclude that diclofenac is transformed by an unknown oxidation reaction involving the nitrogen atom, 
which cannot be detected by TPs, but by N-isotope fractionation. 
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Tab. 3-1 Enrichments factors for diclofenac; 
*
adopted from Maier et al.
17
; n.s. = not significant; 
System εC (‰) εN (‰) 
ABTS n.s. +5.7 ± 0.3 
MnO2 -1.5 ± 0.1 -7.3 ± 0.3 
Biodegradation* n.s. (-0.7 ± 0.3) -7.1 ± 0.4 
Catalyzed Dechlorination* -2.0 ± 0.1 n.s. 
Photodegradation in ultrapure water -1.1 ± 0.1 +2.0 ± 0.1 
Photodegradation in river water -0.7 ± 0.1 +1.9 ± 0.1 
Ozonation, radical scavenger added n.s. +1.5 ± 0.2 
Ozonation, low DOC (1.5 mg L-1) n.s. +1.9 ± 0.2 
3.4.4 Environmental Significance 
This study highlights the ability of CSIA to track and distinguish reaction pathways by revealing the 
variability of isotope fractionation in four different model reactions. N-isotope fractionation was highly 
reaction-specific and could, therefore, serve as a sensitive measure to identify transformation pathways 
of diclofenac in the environment. Since all investigated pathways showed minor or no C-isotope 
fractionation, this can be seen as a weak and non-specific indicator for transformation (Tab. 3-1). Hence, 
we provide a one-dimensional scheme for N-isotope fractionation in Fig. 5, instead of the common dual 
isotope plot that is plotted in the Abstract Art.  
Fig. 3-5 illustrates the ability of N-CSIA to distinguish photo- and biotransformation. Both are 
supposed to be the most important sinks of diclofenac in the environment and CSIA can be used to 
investigate their relative importance. In the case that CSIA is applied as only measure for 
transformation, it can qualitatively distinguish photo- from biotransformation in cases where 
pronounced transformation occurs. If 15N/14N ratios increase, biotransformation is more important than 
phototransformation and vice versa in the case of 14N/15N increase. If the overall extent of 
transformation (Ct/C0 of Equation 3) can in addition be determined by independent means (e.g., the 
combination of conservative tracers and concentration measurements),15, 54 εN,total can even be 
calculated, and the share of biotransformation can then directly be deduced from Fig. 5 and Eq. 5. This 
approach can also be used to compare the efficiency of UV-treatment and biotransformation during 
(waste-) water treatment. 
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Fig. 3-5. Nitrogen isotope enrichment factors (εN,total) reflect the share of biotic- and photolytic 
transformation if both processes occur in parallel according to Eq. 3-4 (with εN,,Bio = -7.1‰ vs. εN,,Photo = 
+1.9‰); the blue and red area indicate the extent of transformation where isotope analysis is a stand-
alone proof for transformation (Δδ
15
N ≥ 1.6‰ = 4σ)  
Moreover, the ability of CSIA to detect diclofenac transformation by MnO2 is not only important for 
mechanistic studies with synthesized MnO2. CSIA can also be used to detect the transformation 
potential of natural manganese oxides which are ubiquitously present in the environment and that were 
recently shown to have able to transform diclofenac.23 
This study underlines that CSIA and TP analysis nicely complement to each other. TP analysis is 
important to be aware of toxic or persistent TPs and if TPs are specific for a certain reaction, they can 
also indicate transformation pathways. However, the mass balance between reactant and TP(s) is 
usually not closed when micropollutants are transformed in the environment and it is unclear if the 
relevant TP(s) are detected. Here, CSIA can provide an independent line of evidence and indicate if the 
detected TPs agree with the observed isotope fractionation, as shown for transformation of diclofenac 
by oxidative SET. In return, if important transformation pathways are not detectable by TP analysis, CSIA 
may jump in, as shown for MnO2- and biotransformation of diclofenac. 
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4.1 Abstract 
Assessing the environmental fate of chiral micropollutants such as herbicides is challenging. The 
complexity of aquatic systems often makes it difficult to obtain hydraulic mass balances, which is a 
prerequisite when assessing degradation based on concentration data. Elegant alternatives are 
concentration-independent approaches like compound-specific isotope analysis (CSIA) or enantiospecific 
concentration analysis. Both detect degradation-induced changes from ratios of molecular species, 
either isotopologues or enantiomers. A combination of both – enatioselective stable isotope analysis 
(ESIA) – provides information on 13C/ 12C ratios for each enantiomer separately. Recently, Badea et al. 
demonstrated for the first time ESIA for the insecticide α-hexachlorocyclohexane. The present study 
enlarges the applicability of ESIA to polar herbicides such as phenoxyacids: 4-CPP (((RS)-2-(4-
chlorophenoxy)-propionic acid), mecoprop (2-(4-Chloro-2-methylphenoxy)-propionic acid) and 
dichlorprop (2-(2,4-Dichlorophenoxy)-propionic acid). Enantioselective GC-IRMS (gas chromatography-
isotope ratio mass spectrometry) was accomplished with derivatisation prior to analysis. Precise carbon 
isotope analysis (2σ ≤0.5‰) was obtained with ≥ 7 ng C on column. Microbial degradation of DCPP by 
Delftia acidovorans MC1 showed pronounced enantiomer fractionation, but no isotope fractionation. In 
contrast, Badea et al. observed isotope fractionation, but no enantiomeric fractionation. Hence the two 
lines of evidence appear to complement each other. They may provide enhanced insight when 
combined as ESIA.  
4.2 Introduction 
Herbicides can help to increase crop yields by killing weeds and pests. However, after application 
their residues end up as micropollutants in aquatic ecosystems.1 Since they have by definition a 
biological impact, they pose a potential threat to human and environmental health. It is therefore 
essential to understand how these compounds behave in complex environmental systems. This is a 
particular challenge for chiral micropollutants, where degradation behavior and toxicity often differs 
between single enantiomers.2 However, in aquatic systems such as surface or ground waters the 
interpretation of measured concentrations relies on the possibility to obtain a closed hydraulic mass 
balance. Without this hydraulic information it is otherwise not possible to distinguish degradation from 
dilution processes. There are two elegant approaches that circumvent this difficulty by analyzing ratios 
that are inherent to the target molecules. 
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One approach is enantiospecific concentration analysis. Here the concentration of the individual 
enantiomers is analyzed and the enantiomer fraction (EF) is expressed as the ratio between one 
enantiomer and the sum of both enantiomers (e.g. EFR=R/[R+S]). Nearly all commercial products have 
either an EF of 0.5 (racemates) or 0 (enatiopure products). During biological processes this ratio can be 
shifted. The reason is that many enzymes that are involved in transformation reactions have an 
enantioselective preference and favor one enantiomer over the other.2 Hence, shifts in the EF can be a 
very useful tool to demonstrate that chiral compounds are degraded in complex environmental systems, 
particularly if other approaches (e.g. mass balances, metabolite analysis) fail.  
Another promising approach to investigate sources and degradation of micropollutants in 
complex environmental systems is compound specific isotope analysis (CSIA). Several studies have 
demonstrated that changes in the isotope ratio of a compound can be used to investigate degradation 
of xenobiotics 3-7. The underlying principle is that (bio-)chemical reactions are commonly associated with 
a kinetic isotope effect, which causes a fractionation of heavy and light isotopes. Using this approach 
isotope fractionation of one element can be used to quantify degradation.8, 9If several elements are 
analyzed, even the mechanisms and pathways of transformation processes can be elucidated6, 10-12 as 
demonstrated recently for selected pesticides.13-16 
CSIA and EF analysis work on the same principle that degradation can be detected because one 
species becomes enriched relative to the other. Despite this similarity, both approaches have been 
applied together in only one study. Recently Badea et al. presented a first example of enantioselective 
isotope analysis (ESIA) applied to the insecticide α-hexachlorocyclohexane.17 In a biodegradation 
experiment they observed isotope fractionation, but no enantiomer fractionation so that the line of 
evidence brought forward in this particular example was similar as for conventional CSIA.  
The aim of this study was to enlarge the applicability of ESIA to a broader range of substances, 
including polar compounds that are more challenging to analyze via GC-IRMS and for a case of 
biodegradation where enantiomer fractionation is well established to occur. To this end an 
enantiospecific stable isotope method was developed for three polar herbicides, 4-CPP ((RS)-2-(4-
chlorophenoxy)-propionic acid), MCPP (mecoprop, 2-(4-Chloro-2-methylphenoxy)propionic acid) and 
DCPP (dichlorprop, 2-(2,4-Dichlorophenoxy)-propionic acid) to provide a tool for investigating their fate 
in environmental systems. For each compound the precision of the method was tested as well as the 
limits of precise isotope analysis. Subsequently, the method was applied to investigate microbial 
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degradation, using the enantioselective strain Delftia acidovorans MC1 and the herbicide DCPP as a 
model compound. 
4.3 Experimental 
4.3.1 Compounds and chemicals 
Acetonitrile (1.25% acetic acid) and n-hexane were purchased from Carl Roth (Karlsruhe, 
Germany) and had LC-MS grade (purity > 0.99). Acetic acid (1.25%) was purchased from Merck 
(Darmstadt, Germany). MCPP (mecoprop, 2-(4-Chloro-2-methylphenoxy)-propionic acid, CAS RN 7085-
19-0) and BF3 (10% in methanol) were purchased from Sigma Aldrich (St. Louis, U.S.A.). 4-CPP ((RS)-2-(4-
chlorophenoxy)-propionic acid, CAS RN 3307-39-9) was purchased from Aldrich Chemistry (Milwaukee, 
USA) and DCPP (dichlorprop, 2-(2,4-Dichlorophenoxy) propionic acid, CAS RN 120-36-5) and R-DCPP 
from Dr. Ehrenstorfer GmbH (Augsburg, Germany). MilliQ water was generated with a Millipore 
Advantage A10 system (Millipore, Molsheim, France). (S)-2-(4-chlorophenoxy)-propionic acid methyl 
ester (S-4-CPP) was synthesized according to the procedure by Nittoli et al.18 and as described in 
Milosevic et al.19. 
4.3.2 Derivatisation with BF3 
Prior to analysis the polar carboxy-group of the analytes was methylated in a similar way as 
described by Chivall et al.20 for fatty acids. To this end sterile filtered samples or standards were 
evaporated in 2 mL amber glass vials to dryness under a gentle stream of N2. 400 µL of BF3 (10% in 
methanol) were added, the vials were sealed with screw caps equipped with PTFE seals and incubated 
for 1 h at 40°C. After cooling the remaining reactant was quenched with 400 µL MilliQ water and the 
methylated analytes were extracted three times with 500 µL n-hexane and transferred to a new vial. If 
necessary, the extracted phase was reduced to 200 µL under a gentle stream of N2 to increase the 
concentration for isotope analysis. The toxic aqueous phase containing HF was disposed in a canister of 
2 M NaOH to quench its toxicity. 
4.3.3 Isotope Analysis 
Depending on the concentrations of extracts, between 1 µL and 4 µL were injected splitless at 
230 °C. The gas chromatograph (TRACE GC Ultra gas chromatograph, Thermo Fisher Scientific, Milan, 
Italy) was equipped with a β-6TBDM column (50m x 0.25 mm, 0.25 µm film; Macherey&Nagel, Düren, 
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Germany). The column was operated with a constant flow velocity of 29 cm s-1 corresponding to a He 
carrier flow rate of 1.4 ml min-1 (GC-IRMS) and 1.0 ml min-1 (GC-TOF-MS). Initial oven temperature was  
80 °C (1 min.), ramped to 140 °C with a rate of 10 °C min.-1, then with 1.5 °C min.-1 to 185 °C and then 
with 30 °C min.-1 to 230 °C (held for 4 min.). After separation the analytes were combusted online in a 
Finnigan GC combustion interface (Thermo Fisher Scientific, Bremen, Germany) to CO2 with a NiO tube / 
CuO-NiO reactor operated at 1000°C (Thermo Fisher Scientific, Bremen, Germany). CO2 isotope values 
were determined with a Finnigan MAT 253 isotope ratio mass spectrometer (Thermo Fisher Scientific, 
Bremen, Germany). Before and after every run three reference gas peaks were measured. These 
reference gas peaks were used to link isotope values to the international standard for carbon isotopes 
(Vienna PeeDee Belemnite, Eq. 4-1). 
      
(            
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 (4-1) 
To validate the results of the GC-IRMS method, in addition pure in-house standards of all 
compounds were characterized on an elemental analyzer (EURO EA, Euro Vector Instruments) coupled 
to a Finnigan MAT 253 isotope ratio mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). 
Calibration was performed with the following organic reference materials provided by the International 
Atomic Energy Agency (IAEA, Vienna): IAEA 600, IAEA CH3 (cellulose), IAEA CH6 (sucrose) and IAEA CH7 
(polyethylene). 
4.3.4 Calculation of the introduced methyl-group 
During methylation an additional carbon atom is introduced in each herbicide molecule and 
changes its bulk carbon isotope ratio. This shift of δ13C was kept constant by using the same batch of 
methanolic BF3 solution for the derivatisation of standards and samples. Values were corrected 
according to the common procedure as described previously.21-23 First, the isotope ratio of the 
introduced methyl group was calculated (δ13C(Me)) (Eq. 4-2). To this end the isotope ratio of the lab 
standard of the respective herbicide was determined prior to methylation on EA-IRMS (δ13C(Analyte)EA) 
and after methylation on GC-IRMS (δ13C(Me-Analyte)GC). With respect to the number of C-atoms of the 
analyte (n), the weighted difference was then used to calculate the theoretical isotope-ratio of the 
introduced methyl-group (Table 4-1). Subsequently this value was used to correct samples (δ13C(Sample)) 
for the introduced methyl-group; again, with respect to the number of carbon atoms (Eq. 4-3). The 
inherent uncertainty of this procedure can be calculated by gaussian error propagation (Eq. 4-4). The 
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uncertainty of the sample value (∆δ13C(Sample)) is strongly influenced by the uncertainty of the GC-IRMS 
analysis (∆GC), whereas the contribution of the methyl group calculation (∆Me) is reduced by a factor of 
1/9 in the case of 4-CPP and DCPP and 1/10 in the case of MCPP, respectively. 
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4.3.5 Peak identity 
Identity of standards and samples was verified on a gas chromatograph (DANI Master-GC, Milano 
Italy) coupled to a time of flight mass spectrometer (DANI Master-TOF, DANI, Italy / Switzerland). The 
system was operated with same flow velocity, temperature conditions and the same column as 
described above for the GC-IRMS system, but without combustion of the samples to CO2.  
One enantiomer of each DCPP and 4-CPP was available as a pure standard, and was used to 
identify the respective enantiomers. There are only small molecular differences in the structure of MCPP 
in comparison to 4-CPP and DCPP and they are not related to the chiral center. Hence it was assumed 
that the elution order of 4-CPP and DCPP, where the R enantiomer elutes first, also applies to MCPP. In 
addition, this elution order agrees with the elution order Buser and Muller1 determined for 4-CPP and 
MCPP with a similar stationary phase. Ideally, this hypothesis remains to be verified with a pure MCPP 
enantiomer for degradation studies with MCPP. 
4.3.6 DCPP transformation study 
A pure strain of Delftia acidovorans MC1 was used for degradation of DCPP. MC1 was first 
pregrown in mineral salt solution (1 L, 30oC) with 10 mg DCPP 24. When DCPP was completely consumed 
by MC1, the final OD of this solution reached 0.4 at 500 nm. Using this solution, biodegradation of DCPP 
(60 mg L-1) was conducted in duplicate non-shaken batches (200 mL each). Liquid samples (5 mL each) 
were collected and sterile filtered (0.22 µm). 0.5 mL sample were immediately analyzed by LC-UV as 
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described below. The rest was stored frozen at -20oC for isotope analysis. DCPP samples were quantified 
using a Shimadzu LC-10A series High Performance Liquid Chromatograph equipped with an Allure C18 
column, 150 × 4.6 mm, 5 µm particle size (Restek, USA) and a Ultra-Violet detector. The eluting solvents 
were acetonitrile with 1.25% acetic acid (solvent A) and de-ionized water with 1.25% acetic acid (solvent 
B). The gradient was composed of 30% solvent B (1 min) and was increased to 80% (2-10 min) and finally 
decreased to 30% (11-12 min) again. The flow rate was 1 mL min-1 and the oven temperature 45 °C. The 
sample injection volume was 100 µL and absorbance of DCPP was measured at 280 nm. 
4.4 Results 
4.4.1 Chromatographic Resolution 
As shown previously by Buser and Müller,1 chlorinated phenoxy acid herbicides can be separated 
on a chiral stationary phase after methylation (Fig. 4-1). We achieved this with a chromatographic 
resolution of R≥ 3.0 for the lowest tested concentrations and R≥ 1.4 for the highest tested 
concentrations when R is defined as retention time difference/ mean peak width.25 If R is calculated 
using the peak width at half height25 a chromatographic resolution between R≥ 7.2 and R≥ 6.2 was 
achieved. Only the highest concentrations of 4-CPP (R≥ 1.4) fall slightly below the conservative definition 
of baseline separation (R≥ 1.5) (Fig. 4-1b). This did not influence the isotope values (Fig. 4-2); however, 
in cases where values appear to be biased, samples can be diluted. 
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Fig. 4-1 GC-IRMS Chromatogram (m/z 44) of a racemic mix, containing 4-CPP, MCPP and DCPP; 
Shown are examples with an injection volume of 1 µL and concentrations per enantiomer of (a) 
12.5 mg L
-1
 and (b) 50 mg L
-1
  
4.4.2 Isotope Analysis 
The precision of ESIA for the three tested herbicides is comparable to other non-enantioselective 
studies that do not contain a derivatisation step.12 Triplicate analysis delivered a standard deviation of 
2 ≤ 0.5‰. Although a methyl-group is introduced in the analytes during derivatisation, the isotope 
values of the GC-IRMS analysis (gas chromatography isotope ratio mass spectrometry) were 
indistinguishable from the reference values derived by elemental analysis-IRMS within the typical 
precision of the two methods (2 of 0.5‰ and 0.2‰, respectively, Tab. 1). This applies for the single 
enantiomers as well as for the racemate value, calculated as the mean of both enantiomers. 
Correspondingly, the isotope ratio of the introduced methyl group was close to the isotopic composition 
of the target compounds (Tab. 4-1), and the methyl group-values were indistinguishable within 
calculated uncertainties. Because the correction scheme described above uses the isotope shift of 
standards for the correction of samples, it delivers precise isotope values with respect to the introduced 
carbon atom as well as for systematic fractionation effects that can appear during derivatization.23 For 
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the purposes of the linearity test we refrained from such corrections, because its focus was on the 
correlation of peak amplitude and isotope value and the correction term would have been the same for 
all samples. For degradation studies, as shown below, the additional methyl group has to be taken into 
account, because position-specific isotope changes are more strongly diluted by the additional carbon 
atom.  
Tab. 4-1 Given are Isotope values of the racemate analyzed on EA-IRMS, the enantiomers analyzed on 
GC-IRMS, the theoretical value of the racemate calculated as the mean value of all values analyzed on 
GC-IRMS (R- and S- enantiomers are denoted as R and S, respectively), the lowest amount needed on 
column for precise isotope analysis for each enantiomer and the calculated δ13C value of the methyl-
group (see Eq. 4-2) introduced during derivatisation; Uncertainties represent the standard deviation. Note 
that the uncertainty of the calculated isotope value of the methyl-group has only minor influence on the 
isotope value of samples as shown in Eq. 4-4. 
Analyte EA-IRMS 
δ13C [‰] 
(n=5) 
GC-IRMS 
δ13C [‰] 
(n=9-13) 
GC-IRMS 
δ13C [‰] 
(n=9-13) 
Lowest amount 
needed for precise 
isotope analysis  
Calculated δ13C of 
introduced methyl-
group [‰] 
4-CPP -26.5 ± 0.1 -26.9 ± 0.3 R  -26.7 ± 0.3 62 pmol 
7 ng C 
-28 ± 3 
 -26.4 ± 0.1 S 
MCPP -28.6 ± 0.1 -29.2 ± 0.2 R -28.9 ± 0.4 58 pmol 
7 ng C 
-32 ± 4 
 -28.6 ± 0.2 S 
DCPP -27.3 ± 0.1 -27.5 ± 0.1 R -27.3 ± 0.2 53 pmol 
6 ng C 
-28 ± 2 
 -27.2 ± 0.2 S 
 
The linear range of the method is illustrated in Fig. 4-2. For all four tested compounds the lower 
limit of precise δ13C isotope analysis was around peak amplitudes of 200 mV. Hence we recommend that 
for precise ESIA only peak amplitudes higher than 200 mV should be used. This corresponds to a 
minimum amount of substance needed on column of ≥ 7 ng that is even below the manufacturer 
specification of 10 ng C.12 A critical point for isotope data evaluation is the background correction. In 
most cases a 5 s interval prior to each peak is used to correct its isotope value. Because enantiomer 
peaks in ESIA have narrow retention times, the tailing of the first eluting enantiomer could interfere 
with the background used for the second eluting enantiomer. Consequently we used the background of 
the first enantiomer to correct peak areas of both enantiomers. 
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Fig. 4-2 Dependency of δ
13
C measurements on the peak amplitude; blue diamonds indicate 
S-enantiomers ( ) and red squares R-enantiomers ( ); the solid line represents the EA-IRMS value of 
the racemate 
4.4.3 Application of ESIA to phenoxy acids 
Biodegradation of DCPP was done in Delftia acidovorans MC1. Interestingly, enantioselective 
degradation of DCPP was observed, but no carbon isotope fractionation occurred to either enantiomer 
(Figure 4-3). Two scenarios can explain the absence of isotope fractionation: either the degrading 
enzyme has no isotopic preference, or the intrinsic kinetic isotope effect of the enzyme was masked. 
Such a masking effect appears if the enzymatic bond cleavage is not the rate limiting-step.11 One 
example could be that transport into the cell is rate-limiting26 as hypothesized for MC1,24, 27 but this has 
to be confirmed in further studies. Our findings contrast with the observation of Badea et al. that 
isotope fractionation, but no enantiomeric fractionation occurred in biodegradation of 
α-hexachlorocyclohexane.17 Consequently, the information of both methods (CSIA and enantiomer 
fractionation) appears to be complementary. 
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Fig. 4-3 DCPP degradation comes along with enantiomeric fractionation (left) and no isotope fractionation 
(right); blue diamonds indicate S-DCPP ( ) and red squares R-DCPP ( ); the experiment was made as 
duplicate; the solid line represents the EA-IRMS value of the racemate 
4.5 Outlook 
With this study we provide a tool to investigate degradation of selected chiral herbicides based on 
the isotope analysis of enantiomers. By widening the application of ESIA to another compound class, we 
obtained the remarkable picture that CSIA and enantiomer fractionation do not seem to be strongly 
related. In other words, the methods may nicely complement each other in the assessment of 
contaminated sites. If only one kind of fractionation occurs – i.e. only enrichment of isotopes,17 or only 
of enantiomers (our study) – ESIA presently has no unique advantage compared to CSIA and enantiomer 
analysis alone. In contrast, the full potential of ESIA will unfold if both processes occur in parallel. First 
evidence for such a scenario has been obtained in the study by Milosevic et al. where enantioselective 
degradation and carbon isotope fractionation of 4-CPP were observed downstream at a landfill site 
under anaerobic conditions.19 There, isotope values of single 4-CPP enantiomers differed up to 3‰. 
Hence, much can be expected to be learned from ESIA in the future with respect to the 
complementarity of both lines of evidence in field applications and with respect to a better process 
understanding. 
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Four years ago transformation product (TP) analysis was the only way to investigate the 
transformation behavior of pharmaceuticals. Although compound specific isotope analysis (CSIA) was 
already established for well-known contaminants, such as toluene1 or chlorinated solvents,2 it was never 
used to study pharmaceutical transformation. One reason was that existing CSIA methods for non-
volatile compounds were usually applied at concentrations in the mg L-1 or high µg L-1 range and even 
sophisticated approached using solid-phase microextraction reached “only” 80 µg L-1 and 2 mg L-1 for 
carbon and nitrogen, respectively.3 Thus, applicability of CSIA was far away from typical concentrations 
of micropollutants. In addition, it was assumed that C-isotope fractionation cannot be detected in 
molecules that contain 15 C-atoms.4 Moreover, before 2011 there was no publication on the coupling of 
enantioselective separation techniques with isotope ratio mass spectrometry, despite the great 
potential of such a method for studying transformation reactions.5 It was, therefore, the aim of the 
present dissertation to develop for the first time a CSIA method for a pharmaceutical and ESIA of 
herbicides to obtain new insights into the fate of micropollutants: 
Sources of pharmaceuticals can be traced by CSIA in the environment. In the absence of 
transformation processes CSIA has the potential for source appointment as shown in Chapter 2 for 
diclofenac and in Appendix A1 for benzotriazole. The underlying principle is that sources can vary in 
their isotopic composition for two reasons. On the one hand, Chapter 2 revealed that already 
commercial gel- and tablet formulations that contain diclofenac as active pharmaceutical ingredient vary 
in their isotopic composition. In addition, this finding indicated the potential for producers to track 
batches and to verify their products, if raw materials for production are chosen carefully and C and N 
isotope ratios of manufactured products are recorded (Chapter 2). On the other hand isotope ratios of 
different sources, such as sewage treatment plants or manure from diclofenac treated cattle, could be 
altered to a different extend by preceding transformation processes as described in chapter 3 and 4. 
Hence, CSIA has the potential to investigate different sources in the environment. 
CSIA can track various transformation reactions of a pharmaceutical. In parallel to Schreglmann 
et al.,6 Chapter 2 brought the application limits of CSIA down to the ng L-1 range. Moreover, Chapter 2 
and 3 could demonstrate that CSIA of diclofenac can track aerobic biotransformation, reductive 
dechlorination, ozonation, photolysis, transformation by MnO2 and single electron oxidation (SET). The 
big advantage of CSIA is that these processes can be monitored by the analysis of isotope ratios, even if 
dilution effects impede an evaluation of concentration measurements. This is important, for example, if 
groundwater dilutes diclofenac concentrations in a river where no transformation takes place. There, 
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concentration measurements alone would give a false positive indication for transformation, but isotope 
ratios would keep constant and indicate the absence of transformation processes. Moreover, CSIA 
cannot only track isolated reactions, but Chapter 3 revealed that N-isotope fractionation is the key to 
divide all tested environmentally relevant reactions into two classes that can be distinguished by their 
different N isotope fractionation trends (Fig. 5-1). Transformation by river sediment and MnO2 causes 
normal N-isotope fractionation, whereas SET, photolysis and ozonation cause inverse N-isotope 
fractionation (Chapter 2 & 3). Hence, CSIA of diclofenac can improve our understanding about key 
processes that eliminate diclofenac in engineered and environmental systems. In knowledge can be 
used in engineered systems to test the efficiency of ozonation in comparison to biotransformation or 
MnO2 in (waste-) water treatment. However, the full strength of CSIA comes into play in environmental 
investigations. There, it is of great interest to distinguish the two (potentially) most important sinks of 
diclofenac in the environment - photo- and biotransformation - and this can be done by N-isotope 
analysis.  
 
Fig. 5-1 Transformation by aerobic river sediment and MnO2 causes normal N-isotope fractionation, 
whereas single electron oxidation, photolysis and ozonation cause inverse N-isotope fractionation; hence, 
CSIA is a valuable tool to determine dominating transformation pathways in environmental and 
engineered systems 
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CSIA delivered surprising mechanistic insights into transformation reactions. On a mechanistic 
level, the present thesis delivered new insights into the transformation of diclofenac, even though its 
environmental behavior has been under investigation for 15 years.7 This was possible because CSIA has 
the unique ability to shed light on transition states of transformation reactions that are specific for a 
certain mechanism and cannot be accessed by other means under environmentally relevant conditions 
(see also 1.2.2). Chapter 3 highlighted the importance of this approach, because CSIA elucidated that 
ABTS oxidizes diclofenac by an outer sphere SET, whereas evidence from isotope fractionation indicated 
a different mechanism with MnO2. Interestingly, the same N-isotope fractionation trend as with MnO2 
was observed in biotransformation by river sediment. Hence, CSIA indicates an unknown transformation 
pathway which may be similar for elimination of diclofenac by river sediment or MnO2 and which 
involves nitrogen atom to a greater extent than indicated by available TP identification (ring 
hydroxylated species) Furthermore, in Chapter 3 CSIA was used for the first time to study micropollutant 
transformation by ozone and delivered strong indication that ozone attacks rather the aromatic ring of 
diclofenac than the N-atom. Because many micropollutants contain aniline structures, the observed N-
isotope fractionation of diclofenac gives the promising outlook that CSIA could also help to understand 
the transformation behavior of other micropollutants during ozonation. 
Isotope ratios and TPs – two complementary approaches. Transformation product analysis of 
Chapter 3 has shown that three different reactants – ozone, ABTS and MnO2 – can transform diclofenac 
into the same TP: diclofenac-2,5-iminoquinone. At the same time CSIA revealed that this was done by at 
least two different reaction mechanisms. Hence, TP analysis and CSIA can be seen as complementary 
approaches. On the one hand CSIA shades light on the reaction mechanism (e.g. site of attack, dominant 
pathway) and improves our understanding of transformation processes. On the other hand TP analysis 
shows us the result of this mechanism, which is important because the behavior of TPs is even less 
investigated and in some cases they can be persistent8 or even more toxic than their precursors.9 
However, future work should also address isotope analysis of TPs. In chapter 3 it was discussed if 
hydroxylation is the driver of isotope fractionation. CSIA of the hydroxylated products could show if the 
depletion of light isotopes in diclofenac (εN= -7.1‰) is reflected in an enrichment of light isotopes in the 
TPs (εN= +7.1‰ ?). In other words, CSIA offers the unique ability to correlate TP formation with reactant 
transformation. 
ESIA combines the advantages of CSIA and enantiomer analysis and opens up new fields. 
Chapter 4 combined the advantages of CSIA and enantioselective analysis to provide a very robust tool 
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that can track the fate of micropollutants, give mechanistic insight into transformation, but in addition it 
has also the potential to determine enzymatic activity when no isotope fractionation can be observed. 
Such a case was investigated in chapter 4, where microbial transformation of dichlorprop caused no 
isotope fractionation, but shifted enantiomeric ratios. On the one hand, this investigation showed that 
ESIA could track this reaction, but on the other hand it also provided ground for a deeper mechanistic 
interpretation. There are two hypotheses for the absence of isotope fractionation. Either the 
transforming enzyme shows no isotopic preference, or transport into cells limited the turnover of 
dichlorprop (see also Fig. 1-3). It is currently under investigation, if dichlorprop transformation by the 
isolated enzyme causes isotope fractionation (Qiu et al., submitted to Environmental Science & 
Technology).  If this enzyme shows an isotopic preference, the absence of isotope fractionation in 
Chapter 4 would deliver a direct evidence for if transport into cells as rate-determining step in the 
microbial transformation of dichlorprop.  
Furthermore, the application of ESIA was not restricted to lab experiments, but was already 
brought to the field (Appendix A2). There, the remarkable picture was obtained that enantiomer and 
isotope ratios of 4-CPP (TP of dichlorprop) were shifted at the same time during transformation under 
anaerobic conditions at a landfill site. Hence, much can be learned from ESIA in the future in field 
applications, but also in terms of a better process understanding. This applies especially, because ESIA 
was only applied to carbon isotopes. CSIA of diclofenac, atrazine10 or isoproturon11 has shown that the 
analysis of a second element can increase the possibilities of isotope analysis fundamentally. Future 
studies will show that this also applies for ESIA, when the δ13C approach of this thesis is combined with 
δ2H analysis.  
In conclusion, this thesis highlighted the potential of isotope ratios to deliver new insights into 
transformation reactions by pioneering CSIA of a pharmaceutical and ESIA of herbicides. Much can be 
expected when future work will transfer the approach of this thesis to one of the other 10,000 
pharmaceuticals on the market,12 or when the possibilities of ESIA will be used to study chiral 
blockbuster drugs, such as ibuprofen or metoprolol.  
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A3-S1 Materials 
Methanol, acetonitrile, n-hexane, water (0.1% acetic acid), pentane, formic acid and acetic acid 
were purchased from Carl Roth (Karlsruhe, Germany) and had LC-MS grade (purity > 0.99). Ethyl acetate, 
diclofenac sodium (CAS Nr. 15307-79-6), BF3 (10% in methanol), 2,6-dichloroaniline and TMSH (0.25 M 
in methanol) were purchased from Sigma Aldrich (St. Louis, U.S.A.). 
A3-S2 LC-MS/MS analysis 
Filtered samples of the biodegradation experiment were quantified and screened for 
transformation products without enrichment with a LC-MS/MS system consisting of an Agilent 1200 
binary pump and an ABSciex API 2000 Q-TRAP mass spectrometer. The system was equipped with a 
Luna C18(2) column (100 x 2 mm, 5 µm particle size, Phenomenex, Aschaffenburg, Germany), and 
operated at a flow rate of 300 µL min.-1. A gradient of acetic acid (0.1%, A) and acetonitrile (B) was used 
for separation as following: A:B = 85:15 (0-3 min.) then to A:B = 30:70 (3-24 min.) and set back to A:B = 
85:15 after 24 min. (held until 29 min.). Ionization was achieved with positive and negative electrospray 
ionization and the screened molecular- and fragment-masses can be found in Table A3-S2. 
Tab. A3-S2. LC-MS/MS settings; Diclofenac (Dic); 4’-hydroxy Diclofenac (4’-OH-Dic); 5-QID (5-
benzoquinone diclofenac); dihydroxyphenly acetic acid (DHPA); 2,6-dichlorophenol (2,6-DCP); 2,6-
dichloroaniline (2,6-DCA); note that due to poor fragmentation for 2,6-DCP & 2,6-DCA the non-
fragmented molecule was detected in Q3; * 2,6-DCA was analyzed in postive electrospray ionization 
mode. 
Analyte 
Diclofenac/ 
13
C6-Dic 
4’-OH-
Dic 
5-BQID DHPA 2,6-DCP 2,6-DCA
*
 
Molecular mass [M-H]
-
 294 / 300 310 308 167 161 162 * 
Fragment mass [M-H]
-
 250 / 256 266 264 123 161 162 * 
Declustering potential -16 -16 -16 -16 -56 26 
Extraction potential -6 -7,5 -7.5 -7.5 -12 12 
Cell exit potential -16 -18 -18 -18 -10 12 
Collision energy -12 -12 -12 -12 -5 5 
Cell exit potential -2 -4 -3 -3 -3 4 
Ion spray voltage -4500 V -4500 V -4500 V -4500 V -4500 V +5500 V 
Source temperature 350 °C 350 °C 350 °C 350 °C 350 °C 350 °C 
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A3-S3 SPE extraction 
Tab. A3-S3. Recovery rates of the SPE in tap water and Isar water; elevated salt concentrations had no 
adverse effects on the efficiency 
500mL Test solution spiked with Diclofenac (c = 666 µg L-1) Recovery Rate 
Spiked tap water 101% ± 1% 
Spiked tap water + salt 1 95% ± 1% 
Spiked Isar water 68% ± 2% 
Spiked Isar water + salt 1 77% ± 5% 
1 Salt added to 500mL:  
82.5 mg NaCl (corresponding to 100 mgL-1 Cl); 79 mg Na2SO4 (corresponding to 100 mgL
-1 SO4
2-); 
40.7 mg KNO3 (corresponding to 50 mgL
-1 NO3
-) 
 
A3-S4 Influence of derivatization agent excess 
 
Fig. A3-S4. A minimum molar excess of Diclofenac:TMSH 1:150 is needed to obtain reproducible δ
13
C 
values. Note that values were not corrected for the introduced methyl-group. 
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S5 Relationship injection volume - isotope ratio 
 
Fig. A3-S5. Increasing Injection volume (blue squares) of a 500 mg L
-1
 standard does not affect δ
15
N 
isotope ratios (red crosses)(reference value EA-IRMS: -1.1‰). Injection volumes higher than 2 µL do not 
increase the amplitude gain linearly. Given are mean values and standard deviation (n=4). 
A3-S6 Preparative HPLC-UV 
To purify an enriched sample after extraction by SPE preparative HPLC was conducted. The system 
consisted of a Shimadzu LC-10A HPLC-UV that was equipped with an Allure C18 column (150 x 4.6 mm, 
5 µm particle size, Restek, Bellefonte, U.S.A.) and a fraction collector FRC-10A. It was operated at a flow 
rate of 800 µL min-1 and a gradient of phosphoric acid (5mM A) and acetonitrile (B) was used for 
separation as following: A:B = 90:10 (0-1 min) then to A:B = 20:80 (1-25 min) hold for 3 min (25-28min) 
and then set back to A:B = 90:10 for 5 min (28 - 33 min). Diclofenac was detected at 220 nm. The sample 
was purified by injecting 333µL aliquots manually into a 500 µL loop and a 2 mL fraction was collected as 
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shown in the chromatogram below (S4). The collected fractions were unified and dried before 
derivatization. 
 
 
Fig. A3-S6. HPLC-UV Chromatogram of diclofenac (220 nm, RT 23.5 min) conducted after SPE. The blue 
box (22.5 - 25 min) indicates the fraction that was collected and subsequently dried and derivatized for 
on-column-GC-IRMS analysis . 
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A3-S7 Relationship peak amplitude - isotope ratios 
 
Fig. A3-S7a. Carbon isotope ratios show no dependency on amplitude height; solid line stands for EA-
IRMS values and the dotted line for 2σ (0.8‰) 
 
Fig. A3-S7b. Nitrogen isotope ratios show no dependency on amplitude height; solid line stands for EA-
IRMS value and the dotted line for 2σ (0.8‰) 
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Fig. A3-S7c. Nitrogen isotope ratios using on column injection technique show no dependency on 
amplitude height; solid line stands for EA-IRMS value and the dotted line for 2σ (0.8‰); lowest analyzed 
standards had a diclofenac concentration of 200 mg L
-1
. This analysis was done as a first test for the 
applicability of the on-column technique on an established system 1 and differed from the final GC 
method by: using a RXI-5MS column (60 m × 0.25 mm, 1 µm film thickness, Restek, Bad Homburg, 
Germany); the GC program started at 40 °C (240 s) and was ramped at 10 °C min
-1
 to 290 °C (600 s). 
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A3-S8 Dissipation kinetics and transformation products during biodegradation 
 
Fig. A3-S8a. Dissipation behavior of diclofenac and formation of 4’-OH-diclofenac during oxidative 
transformation in three replicates with river water and sediment (Bottle 1-3) and in the sterile control. 
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Fig. A3-S8b. LC-MS/MS Chromatogram ([m/z]
-
 310/266) of a 4’-hydroxy diclofenac standard (red) and 
sample B3-14 at the end of the incubation (86 d); corresponding mass spectra can be found in S8b. 
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Fig. A3-S8c. mass spectra of sample B3-14, top to bottom, mas: (1) full scan (background subtracted) of 
TP peak at 17.8 min. and the (2) corresponding product ion scan of m/z 310 at 17.8 min.;  (3) product ion 
scan of m/z 310 at 17.7 min of a 4’-hydroxy-diclofenac standard. All dominant fragment-ions of the 
standard are present at a similar ratio in the sample: [M-H]
-
  m/z 310, [M-H-CO2]
-
 m/z 266, [M-H-CO2-
HCl]
-
 m/z 230. 
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S9. GC-IRMS analysis of spiked river water  
 
Fig. A3-S9. GC-IRMS Chromatogram of spiked river water  (c(diclofenac) = 1 µg L
-1
) and a methylated 
diclofenac lab standard. The retention time (RT = 1668 ± 2 s) agrees well between the sample (δ
13
C 
(orange), δ
15
N (blue)) and the lab standard (δ
15
N (green)). Isotope ratios were in perfect agreement with 
EA-IRMS data: δ13C river water -26.4 ± 0.5‰ (EA-IRMS:  -26.4‰) δ
15
N river water -1.2 ± 0.4‰ 
(EA-IRMS: -1.1‰). 
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S1 Materials 
Methanol, acetonitrile, n-hexane, water (0.1% acetic acid) and acetic acid were purchased from Carl 
Roth (Karlsruhe, Germany) and had LC-MS grade (purity > 0.99). Diclofenac sodium (CAS Nr. 15307-79-
6), 13C6-diclofenac, 4’hydroxyl-diclofenac and BF3 (10% in methanol) were purchased from Sigma Aldrich 
(St. Louis, U.S.A.). 
S2 LC-MS/MS analysis 
Filtered samples were quantified and screened for transformation products without enrichment with a 
LC-MS/MS system consisting of an Agilent 1200 binary pump and an ABSciex API 2000 Q-TRAP mass 
spectrometer. The system was equipped with a Luna C18(2) column (100 x 2 mm, 5 µm particle size, 
Phenomenex, Aschaffenburg, Germany), and operated at a flow rate of 300 µL min-1. A gradient of acetic 
acid (0.1%, A) and acetonitrile (B) was used for separation as following: A:B = 85:15 (0-3 min) then to A:B 
= 30:70 (3-24 min) and set back to A:B = 85:15 after 24 min (held until 29 min). Ionization was achieved 
with negative electrospray ionization and the screened molecular- and fragment-masses can be found in 
Table A4-S2. 
Tab. S2. LC-MS/MS settings for Diclofenac (Dic), 4’-hydroxy Diclofenac (4’-OH-Dic), 8-chlorocarbazole 
acetic acid (TP1), carbazole acetic acid (TP2a) and 8-hydroxycarbazole acetic acid (TP2b) 
Analyte 
Diclofenac / 
13
C6-Dic 
4’-OH-Dic TP1 TP2a TP2b 
Molecular mass [M-H]- 294 / 300 310 258 224 240 
Fragment mass [M-H]- 250 / 256 266 214 180 196 
Declustering potential -16 -16 -16 -16 -16 
Extraction potential -6 -7,5 -6 -6 -6 
Cell exit potential -16 -18 -16 -16 -16 
Collision energy -12 -12 -12 -12 -12 
Cell exit potential -2 -4 -2 -2 -2 
Ion spray voltage -4500 V -4500 V -4500 V -4500 V -4500 V 
Source temperature 350 °C 350 °C 350 °C 350 °C 350 °C 
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S3 Detection of TPs during Phototransformation 
 
Fig. S3a. Time series of diclofenac (right axis) phototransformation in river and ultra-pure water and 
formation of three TPs (left axis): 8-chlorocarbazole acetic acid (TP1), carbazole acetic acid (TP2a) and 
8-hydroxycarbazole acetic acid (TP2b)  
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Fig. S3b. Reactions scheme of diclofenac during phototransformation
1
 
S4. Formation of diclofenac-2,5-iminoquinone in the presence of O3, ABTS or MnO2
 
Fig. S4. Formation of diclofenac-2,5-iminoquinone ([M+H]
+
 = 310.002 ± 0.005 Da) during transformation 
by ABTS and MnO2 and during ozonation with and without the hydroxyl-radical scavenger tert-butanol (t-
BuOH); the y-axis can be interpreted as an approximate yield of TP formation, although ionization 
efficiency may be different for diclofenac and diclofenac-2,5-iminoquinone; diclofenac-2,5-iminoquinone 
was also found by Forrez et al.
2
 during MnO2 transformation and by Sein et al.
3
 during ozonation  
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S5 Calculation of pseudo-first order constants of hydroxyl radicals 
A comparison of the pseudo-first order constants of reactions with ozone and hydroxyl radical indicates 
that reaction with ozone are expected to be 105 times faster:  
kOH’ = [OH(dot)]· kOH  = 7.5 × 10
-3 s-1  (A4-1) 
[OH(dot)] = 10-12 M ; 4 kOH  = 7.5 × 10
9 M-1 s-1; 5   
kO3’ = [O3]· kO3  = 10
3 s-1  (A4-2) 
[O3] = 10
-3 M ; kO3· = 10
6 M-1 s-1; 5   
 
S6 Detection of coupling TPs during transformation by ABTS
 
Fig. S5a. LC-Orbitrap Full scan of ABTS experiment (positive ESI); several coupling products with high 
molecular mass appear when diclofenac is transformed by ABTS; none of these TPs is present at t=0 
(data not shown)  
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Fig. S5b. Selected ion trace chromatogram of m/z 589.02 (positive LC-ESI-Orbitrap analysis) and the 
diclofenac dimer peak at 18.38 min 
 
Fig. S5c. Spectrum of diclofenac-dimer peak at 18.38 min; the molecular mass fits perfectly to the 
proposed molecular mass of [M+H]
+
 (589.025) and the chlorine isotope pattern is in perfect agreement 
with the presence of four Cl-atoms; note that the given molecular structure is only a suggestion, since the 
coupling position was not elucidated 
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S7. Detection of OH-diclofenac during MnO2 transformation 
 
 
Fig. S6. Concentrations of diclofenac (left axis) and hydroxy-diclofenac (right axis) during oxidation by 
MnO2; note that hydroxy-diclofenac was not present at t = 0 min, but its first data point corresponds to t = 
10 min.; hydroxylated diclofenac was quantified with a 4’hydroxy-diclofenac standard 
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